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Explanation and Elaboration Document for the STROBE-Vet
Statement: Strengthening the Reporting of Observational Studies in
Epidemiology—Veterinary Extension
A.M. O’Connor, J.M. Sargeant, I.R. Dohoo, H.N. Erb, M. Cevallos, M. Egger, A.K. Ersbøll,
S.W. Martin, L.R. Nielsen, D.L. Pearl, D.U. Pfeiﬀer, J. Sanchez, M.E. Torrence, H. Vigre, C. Waldner,
and M.P. Ward
The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement was ﬁrst published in
2007 and again in 2014. The purpose of the original STROBE was to provide guidance for authors, reviewers, and editors
to improve the comprehensiveness of reporting; however, STROBE has a unique focus on observational studies. Although
much of the guidance provided by the original STROBE document is directly applicable, it was deemed useful to map
those statements to veterinary concepts, provide veterinary examples, and highlight unique aspects of reporting in veteri-
nary observational studies. Here, we present the examples and explanations for the checklist items included in the
STROBE-Vet statement. Thus, this is a companion document to the STROBE-Vet statement methods and process docu-
ment (JVIM_14575 “Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in
Epidemiology—Veterinary (STROBE-Vet) Statement” undergoing prooﬁng), which describes the checklist and how it was
developed.
Key words: Animal Health; Animal welfare; Food Safety; Observational studies; Production; Reporting guidelines.
In veterinary research, observational studies are com-monly used to describe the natural history of disease,
assess etiology, and identify and investigate the eﬀect of
risk factors. To maximize the value of observational stud-
ies, it is critical that they are reported in a manner that
facilitates internal and external validity assessment.
Reporting guidelines allow researchers to appraise the
published ﬁndings and potentially apply them to future
research or decision making. Initially used for interven-
tion (clinical trial) assessments, the CONSORT1,2 and
REFLECT statements3,4 were developed to create an
experimental and reporting framework for randomized
controlled trials and to help authors, reviewers, and
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editors address concerns about incomplete reporting. The
STROBE (Strengthening the Reporting of Observational
Studies in Epidemiology) statement, ﬁrst published in
2007 and again in 2014,5–7 provided a similar framework
for observational studies. In this document, we provide
the rationale behind the revision of STROBE for use in
veterinary research and examples of data reporting under
the revised guidelines. Although much of the STROBE
material is directly relevant to veterinary studies, animal
health investigations have suﬃcient unique features to
warrant publishing a set of veterinary-investigator-
speciﬁc guidelines (JVIM_14575 “Methods and Processes
of Developing the Strengthening the Reporting of Obser-
vational Studies in Epidemiology—Veterinary (STROBE-
Vet) Statement” undergoing prooﬁng). For example,
multiple levels of organization are common in animal
populations, and observational studies should account
for this when reporting results. Given the importance of
population structures when interpreting results, this issue
features prominently in the STROBE-Vet extension.
Omission or unclear reporting of important details is
a common problem in all types of research reports.
Some omissions can seriously limit the utility of the
research by either hiding limitations or creating unwar-
ranted doubt about the studies’ conclusions. These
omissions, in turn, increase research wastage.8–13 Study
results are usually used by people other than the manu-
script authors to make decisions. Hence, these users
need as much information as possible to judge the
validity of the results. Reporting guidelines are designed
to reduce critical omissions by providing a checklist of
important items to include in the report. Checklists
improve author, editor, and reviewer compliance with
respect to what information should be included in a
comprehensive report, making them valuable research-
reporting tools.14,15
How to Use This Document
Each item is presented in the same manner: ﬁrst the
item number (1–22) with subdivisions and a descrip-
tion of the item, followed by examples that illustrate
the reporting approach for the item and a discussion
of the rationale for their inclusion. Ideally, the exam-
ples chosen would illustrate all of the key concepts
and only those concepts. However, it was not always
possible to identify such speciﬁc real-world examples
from the veterinary literature. The working group
decided not to use human healthcare or hypothetical
examples. As a consequence, the examples sometimes
include additional examples or several examples were
needed to illustrate the key concepts. When the expla-
nation for an item was the same as that reported in
the original STROBE publication, we used the mate-
rial ad verbatim, with permission from the original
authors. Examples of poorly reported items were not
included due to space considerations and the consensus
that their inclusion would not substantially increase
understanding or adoption of the guidelines. A table
with the STROBE-Vet checklist is included at the end
of this document (Table 1).
Title and Abstract
The purpose of the abstract and title is to quickly
allow the reader to identify the topic of the research,
the general design of the study, the main results, and
the implications of the ﬁndings.
1(a) Indicate that the Study was an
Observational Study and, If Applicable, Use a
Common Study Design Term
Example 1
Title: “An observational study with long-term follow-
up of canine cognitive dysfunction: Clinical characteris-
tics, survival, and risk factors”.16
Example 2
Title: “Case-control study of risk factors associated
with Brucella melitensis on goat farms in Peninsular
Malaysia”.17
Explanation
Including the study design term in the title or abstract
when a standard study design is used, or at least identifying
that a study is observational, allows the reader to easily
identify the design and helps to ensure that articles are cor-
rectly indexed in electronic databases.18 In STROBE, item
1a only requests that a common study design term be used.
However, in veterinary research, not all observational stud-
ies are easily categorized into cohort, case-control, or
cross-sectional study designs. Therefore, we recommend
including that the study was observational and, if possible,
the study design or important design characteristics, for
example, longitudinal, in the title.
1(b) Indicate Why the Study was Conducted, the
Approach, the Results, the Limitations, and the
Relevance of the Findings
Example
Methicillin-resistant Staphylococcus pseudintermedius
(MRSP) has emerged as a highly drug-resistant small
animal veterinary pathogen. Although often isolated
from outpatients in veterinary clinics, there is con-
cern that MRSP follows a veterinary-hospital associ-
ated epidemiology. This study’s objective was to
identify risk factors for MRSP infections in dogs and
cats in Germany. Clinical isolates of MRSP cases
(n = 150) and methicillin-susceptible S. pseudinter-
medius (MSSP) controls (n = 133) and their corre-
sponding host signalment and medical data covering
the six months prior to staphylococcal isolation were
analysed by multivariable logistic regression. The
identity of all MRSP isolates was conﬁrmed through
demonstration of S. intermedius-group speciﬁc nuc
and mecA. In the ﬁnal model, cats (compared to
dogs, OR: 18.5, 95% CI: 1.8–188.0, P = .01), ani-
mals that had been hospitalised (OR: 104.4, 95% CI:
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Table 1. STrengthening the Reporting of OBservational studies in Epidemiology statement checklist for Veterinary
medicine (the STROBE-Vet statement)
Item
Title and Abstract 1 (a) Indicate that the study was an observational study and, if applicable, use a common study
design term
(b) Indicate why the study was conducted, the design, the results, the limitations, and the relevance
of the ﬁndings
Background/Rationale 2 Explain the scientiﬁc background and rationale for the investigation being reported
Objectives 3 (a) State speciﬁc objectives, including any primary or secondary prespeciﬁed hypotheses or their
absence
(b) Ensure that the level of organizationa is clear for each objective and hypothesis
Study design 4 Present key elements of study design early in the paper
Setting 5 (a) Describe the setting, locations, and relevant dates, including periods of recruitment, exposure,
follow-up, and data collection
(b) If applicable, include information at each level of organization
Participantsb 6 Describe the eligibility criteria for the owners/managers and for the animals, at each relevant level
of organization
Describe the sources and methods of selection for the owners/managers and for the animals, at each
relevant level of organization
Describe the method of follow-up
(d) For matched studies, describe matching criteria and the number of matched individuals per
subject (eg, number of controls per case)
Variables 7 (a) Clearly deﬁne all outcomes, exposures, predictors, potential confounders, and eﬀect modiﬁers.
If applicable, give diagnostic criteria
(b) Describe the level of organization at which each variable was measured
(c) For hypothesis-driven studies, the putative causal structure among variables should be described
(a diagram is strongly encouraged)
Data Sources/Measurement 8* (a) For each variable of interest, give sources of data and details of methods of assessment
(measurement). If applicable, describe comparability of assessment methods among groups and
over time
(b) If a questionnaire was used to collect data, describe its development, validation, and
administration
(c) Describe whether or not individuals involved in data collection were blinded, when applicable
(d) Describe any eﬀorts to assess the accuracy of the data (including methods used for “data
cleaning” in primary research, or methods used for validating secondary data)
Bias 9 Describe any eﬀorts to address potential sources of bias due to confounding, selection,
or information bias
Study Size 10 (a) Describe how the study size was arrived at for each relevant level of organization
(b) Describe how nonindependence of measurements was incorporated into sample-size
considerations, if applicable
(c) If a formal sample-size calculation was used, describe the parameters, assumptions, and methods
that were used, including a justiﬁcation for the eﬀect size selected
Quantitative Variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which
groupings were chosen, and why
Statistical Methods 12 (a) Describe all statistical methods for each objective, at a level of detail suﬃcient for a
knowledgeable reader to replicate the methods. Include a description of the approaches to variable
selection, control of confounding, and methods used to control for nonindependence of observations
(b) Describe the rationale for examining subgroups and interactions and the methods used
(c) Explain how missing data were addressed
(d) If applicable, describe the analytical approach to loss to follow-up, matching, complex sampling,
and multiplicity of analyses
(e) Describe any methods used to assess the robustness of the analyses (eg, sensitivity analyses or
quantitative bias assessment)
Participants 13* (a) Report the numbers of owners/managers and animals at each stage of study and at each relevant
level of organization—for example, numbers eligible, included in the study, completing follow-up,
and analyzed
(b) Give reasons for nonparticipation at each stage and at each relevant level of organization
(c) Consider use of a ﬂow diagram, a diagram of the organizational structure, or both
Descriptive Data on
Exposures and
Potential Confounders
14* (a) Give characteristics of study participants (eg, demographic, clinical, social) and information on
exposures and potential confounders by group and level of organization, if applicable
(b) Indicate number of participants with missing data for each variable of interest and at all relevant
levels of organization
(c) Summarize follow-up time (eg, average and total amount), if appropriate to the study design
(continued)
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21.3–511.6, P < .001), or visited veterinary clinics
more frequently (>10 visits OR: 7.3, 95% CI: 1.0–
52.6, P = .049) and those that had received topical
ear medication (OR: 5.1, 95% CI: 1.8–14.9,
P = .003) or glucocorticoids (OR: 22.5, 95% CI: 7.0–
72.6, P < .001) were at higher risk of MRSP infec-
tion, whereas S. pseudintermedius isolates from ears
were more likely to belong to the MSSP group (OR:
0.09, 95% CI: 0.03–0.34, P < .001). These results
indicate an association of MRSP infection with vet-
erinary clinic/hospital settings and possibly with
chronic skin disease. There was an unexpected lack
of association between MRSP and antimicrobial
therapy; this requires further investigation. . .19
Explanation
The abstract provides key information that enables
readers to understand the key aspects of the study and
decide whether to read the article. In STROBE, item 1b
recommended that authors provide an informative and
balanced summary of what experiments were done, what
results were found, and the implications of the ﬁndings in
the abstract. In STROBE-Vet, this item was modiﬁed to
provide more guidance on the key components that
should be addressed. The study design should be stated;
however, if the study does not correspond to a named
study design such as case-control, cross-sectional, and
cohort study, then the author should describe the key ele-
ments of the study design such as incident versus preva-
lent cases, and whether or not the selection was based on
outcome status.20 The abstract should succinctly describe
the study objectives, including the primary objective and
primary outcome, the exposure(s) of interest, relevant
population information such as species and the purpose
(or uses) of the animals, the study location and dates, and
the number of study units. In addition, including the
organizational level at which the outcome was measured
(eg, herd, pen, or individual) is recommended. The pre-
sented results should include summary outcome measures
(eg, frequency or appropriate descriptor of central ten-
dency such as mean or median) and, if relevant, a clear
description of the association direction along with
accompanying association measures (eg, odds ratio) and
measures of precision (eg, 95% conﬁdence interval)
rather than P-value alone. We discourage stating that an
exposure is or is not signiﬁcantly associated with an out-
come without appropriate statistical measures. Finally,
because many veterinary observational studies evaluate
multiple potential risk factors, the abstract should pro-
vide the number of exposure-outcome associations tested
to alert the end user to potential type I error in the study.
When multiple outcomes are observed, provide the
reader with a rationale for the outcomes presented in the
abstract, for example, only statistically signiﬁcant results
or the outcome of the primary hypothesis is presented.
Table 1. (Continued)
Item
Outcome Data 15* (a) Report outcomes as appropriate for the study design and summarize at all relevant levels
of organization
(b) For proportions and rates, report the numerator and denominator
(c) For continuous outcomes, report the number of observations and a measure of variability
Main Results 16 (a) Give unadjusted estimates and, if applicable, adjusted estimates and their precision (eg, 95%
conﬁdence interval). Make clear which confounders and interactions were adjusted. Report all
relevant parameters that were part of the model
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful
time period
Other Analyses 17 Report other analyses done, such as sensitivity/robustness analysis and analysis of subgroups
Key Results 18 Summarize key results with reference to study objectives
Strengths and Limitations 19 Discuss strengths and limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other relevant evidence
Generalizability 21 Discuss the generalizability (external validity) of the study results
Transparency 22 (a) Funding—Give the source of funding and the role of the funders for the present study and,
if applicable, for the original study on which the present article is based
(b) Conﬂicts of interest—Describe any conﬂicts of interest, or lack thereof, for each author
(c) Describe the authors’ roles—Provision of an author’s declaration of transparency is recommended
(d) Ethical approval—Include information on ethical approval for use of animal and human subjects
(e) Quality standards—Describe any quality standards used in the conduct of the research
aLevel of organization recognizes that observational studies in veterinary research often deal with repeated measures (within an animal
or herd) or animals that are maintained in groups (such as pens and herds); thus, the observations are not statistically independent. This
nonindependence has profound implications for the design, analysis, and results of these studies.
bThe word “participant” is used in the STROBE statement. However, for the veterinary version, it is understood that “participant”
should be addressed for both the animal owner/manager and for the animals themselves.
*Give such information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in
cohort and cross-sectional studies.
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Introduction
The aim of the introduction is to allow the reader to
understand the study’s context and the results’ potential
to contribute to current knowledge.
2 Background/Rationale: Explain the Scientiﬁc
Background and Rationale for the Investigation
Being Reported
Example
The syndesmochorial placenta of cattle prevents the
bovine fetus from receiving immunoglobulins in
utero; therefore, calves are born essentially agamma-
globulinemic []a. Calves acquire passive immunity by
consuming colostrum in the ﬁrst 24–36 h of life [].
Inadequate colostrum consumption leads to failure
of passive transfer (FPT), which has detrimental
eﬀects on calf health and survival. As many as 40%
of dairy calves experience FPT []. However, beef
and dairy calf management is considerably diﬀerent,
as beef calves generally remain with the cow post-
calving and nurse ad libitum, while dairy producers
often separate calves from their dams and then pro-
vide the colostrum. Hence, the prevalence of and
risk factors for FPT in beef calves may vary sub-
stantially from those in reports describing dairy
calves. . ..21
Explanation
The scientiﬁc background provides important context
for readers. It describes the focus, gives an overview of
what is known on a topic and what gaps in current
knowledge are addressed by the study. Background
material should note recent pertinent studies and any
reviews of pertinent studies. The background section
should also include the anticipated impact of the work.
3(a) Objectives: State Speciﬁc Objectives,
Including any Primary or Secondary Prespeciﬁed
Hypotheses or their Absence
Example
The objective of this study was to investigate the
eﬀect of track way distance and cover on the proba-
bility for lameness in Danish dairy herds using graz-
ing. We hypothesised that short track distances with
added cover would be associated with the lowest
lameness prevalence.22
Explanation
Objectives are the detailed aims of the study. Well-
crafted objectives specify populations, exposures and
outcomes, and parameters that will be estimated. They
might be formulated as speciﬁc hypotheses or as ques-
tions that the study was designed to address. In some
situations, objectives might be less speciﬁc, for example,
in early discovery phases. Regardless, the report should
clearly reﬂect the investigators’ original intentions.
3(b) Ensure that the Level of Organization is
Clear for Each Objective and Hypothesis
Example
There were three objectives for this study: (1) to
quantify the standing and lying behavior, with par-
ticular emphasis on post-milking standing time, of
dairy cows milked 39/d, (2) to determine the cow-
and herd-level factors associated with lying behavior,
and (3) to relate these ﬁndings to the risk of experi-
encing an elevation in somatic cell count (SCC).23
Explanation
A full explanation is provided in Box 4: Organization
structures in animal populations.
Methods
The aim of the methods section is to describe what
experiments were planned and performed in suﬃcient
detail for the reader to understand them; judge whether
they were adequate with respect to providing reliable,
valid answers to the objectives and hypotheses; and
assess whether deviations from the original research
plan were justiﬁed.
4 Study Design: Present Key Elements of Study
Design Early in the Paper
Example
A cohort study was performed on two farrow-to-ﬁn-
ish farms (A and B) in two farrowing rooms (co-
horts) per farm. Sows were examined for the
presence of A. pleuropnemoniae infection by collec-
tion of blood and tonsil brush samples approxi-
mately 3 weeks before parturition. The proportions
of colonization at litter and individual piglet level
were determined 3 days before weaning and associa-
tions with dam parity and sow serum and brush
sample results were evaluated.24
Explanation
We advise presenting key elements of study design
early in the methods section (or at the end of the intro-
duction) so that readers can understand the basics of
the study. For example, if the authors used a cohort
study design, which followed animals or animal groups
over a particular time period, they should describe the
group that comprised the cohort and their exposure sta-
tus. Similarly, if the investigation used a case-control
design, the cases and controls and their source popula-
tion(s) should be described.
If a study is a variant of the three main study types
(cohort, case-control, or cross-sectional), there is an
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additional need for clarity. Authors can provide a clear
description of the study design by including the follow-
ing key elements: (1) the timing of study population
enrollment with respect to the occurrence of the out-
come such as after or prior to, (2) the role of exposure
status on enrollment such as enrolled based on exposure
or not, (3) the role of outcome status on enrollment
such as enrolled based on outcome or not, (4) the tim-
ing of outcome and exposure determination such as
outcome determined before, after, or concurrent to
exposure determination, and (5) if the outcome is a dis-
ease, condition, or behavior, whether the outcome rep-
resents incidence or prevalence. If the study only
estimates prevalence or incidence in a single group, then
the authors need to clarify whether the outcome repre-
sents incidence or prevalence. This item is intended to
give the reader a general idea of the study design. The
design speciﬁcs are described in detail in subsequent
items.
We recommend that authors refrain from calling a
study “prospective” or “retrospective” because these
terms are ill deﬁned.25 One usage sees cohort and
prospective as synonymous and reserves the word retro-
spective for case-control studies. A second usage distin-
guishes prospective and retrospective cohort studies
according to the timing of data collection relative to
when the idea for the study was developed.26 A third
usage distinguishes prospective and retrospective case-
control studies depending on whether the data about
the exposure of interest existed when cases were
selected.27
In STROBE-Vet, we do not use the words prospec-
tive and retrospective, nor alternatives such as concur-
rent and historical. We recommend that, whenever
authors use these words, they deﬁne what they mean.
Most importantly, we recommend that authors
describe exactly how and when data collection took
place.
5(a) Setting: Describe the Setting, Locations, and
Relevant Dates, Including Periods of
Recruitment, Exposure, Follow-Up, and Data
Collection
5(b) If Applicable, Include Information at Each
Level of Organization
Example
This study was conducted in Afar and Tigray
regions in north-eastern Ethiopia. Two administra-
tive zones (Zone-1 and Zone-4) out of ﬁve zones of
Afar region were included in the study, and then
one district from each zone was selected (Asiyta and
Yallo, respectively). Asayita district was selected to
include an agro-pastoral production system where
irrigation farming is widely prevalent. . . . Yallo was
selected for its location interfacing with the highland
agro-climate in Alamata and Raya Azebo districts
where the livestock are moved for grazing and
watering during dry season []. There were two dis-
tinct agro-ecological climates prevailing in the Afar
study area: lowland (<1,500 m) and highland
(>2,300 m). . .
A cross-sectional study was carried out between
October 2011 and February 2012 to assess epidemi-
ological factors associated with observed [lumpy
skin disease] in the previous 2 years (September
2009 to October 2011). Three to four Kebeles (the
lowest administrative unit next to district in order
of hierarchy in Ethiopia) were selected randomly
from each district, and 20–30 herds were randomly
selected from each Kebele. Herd-owners were
selected based on willingness to complete the
questionnaire.28
Explanation
Readers must understand the clinical, demographic,
managerial, geographic, and temporal contexts in which
the study was conducted, so readers will be able to
determine the populations to which the study’s infer-
ences can be applied. Data from research herds or ken-
nels might not extrapolate to commercial or home
settings. Dates are required to understand the historical
context of the research, because medical, sociological,
and agricultural practices can change over time, which,
in turn, can aﬀect the prevalence of risk factors, poten-
tial confounders, diseases, and study methods. Knowing
when a study took place and over what period partici-
pants were recruited and followed places the study in
historical context and is important for the interpretation
of results.
6 Participants
6(a) Describe the Eligibility Criteria for the
Owners/Managers and for the Animals, at Each
Relevant Level of Organization
Example
Counties were chosen based on the proportion of
registered backyard ﬂock owners and location of
commercial industries and auction markets. In May
2011, the Maryland Department of Agriculture
(MDA) conﬁdentially mailed 1,000 informational
letters and return postcards to poultry owners
enrolled in the Maryland Poultry Registration Pro-
gram. Participants were eligible for the study if
they lived in Maryland, owned domesticated fowl,
and maintained a ﬂock size fewer than 1,000
birds.29
Explanation
Eligibility criteria might be presented as inclusion
and exclusion criteria, although this distinction is not
always necessary or useful. Regardless, we advise
authors to report all eligibility criteria and also to
describe the group from which the study population
was selected (eg, the general population of a region or
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country), and the method of recruitment (eg, referral
or self-selection through advertisements). Authors of
studies involving animal populations should describe
the eligibility criteria at all organizational levels (eg,
farm, pen, stable, or clinic) for the animals included,
and for smaller units within included animals, such
as limbs or mammary quarters, if applicable
(see Box 4: Organization structures in animal
populations).
6(b) Describe the Sources and Methods of
Selection for the Owners/Managers and for the
Animals, at Each Relevant Level of Organization
Example
All MRSP isolates identiﬁed between October 2010
and October 2011 inclusive were considered. MSSP
isolates were selected throughout the study period
using simple randomization on www.randomizer.
org.19
Data and pedigree information were obtained from
the Swedish Dairy Association (Stockholm, Sweden),
and the Swedish organic certiﬁcation organization
(KRAV; Uppsala, Sweden) contributed information
about dairy farms with organic plant production. . . .
The initial data set contained records from 402
organic herds (all herds with available data) and
5,335 . . .. conventional herds (herds with an even last
number in the herd identity).30
Explanation
There are many ways eligible study units can be
selected, and when multiple organizational levels are
used, the selection approach might diﬀer based on the
level. For example, random selection might be used at
one level and convenience sampling at another. Clear
and transparent descriptions of the selection approach
for eligible study units enable identiﬁcation of the pop-
ulation to which the study results can be inferred and
any potential selection biases. When nonprobability
sampling (eg, convenience, haphazard, or snowball
methods) is used, indicate this explicitly and provide a
rationale for its use.
6(c) Describe the Method of Follow-Up
Example 1
After surgery, the owners of the dogs were instructed
to monitor for any signs of new mammary tumors
and notify the principal investigator (PI) if any signs
of recurrence or new tumors were noted. In addition,
they were contacted by the PI (VK) every 6 months
through phone to ensure this information. . . . Dogs
with reported/suspected new tumors were requested
to return for clinical examination and
conﬁrmation.31
Example 2
Table 1 Possible outcomes of horses on cohort32
Possible outcome Action
No further colic during study Censored
Colic resolves without
medication
Horse returns to population
at risk 48 h after colic episode
Colic requires medical
attention—clinical
records obtained
Horse returns to population
at risk 48 h after colic episode
Colic requires surgery Surgical diagnosis and end of
contribution to time at risk
Death from other causes Censored
Dropout of cohort Censored/loss to follow-up
Explanation
The potential for loss to follow-up diﬀers between
studies; therefore, follow-up monitoring approaches
might diﬀer between studies. For example, companion
animal populations that rely on client return visits
are prone to loss to follow-up, analogous to the
human population studies discussed in STROBE. The
authors of these studies often make several attempts
to contact animal owners to determine their pet’s out-
come. In other animal populations, data might be
collected from computerized systems, such as herd
inventory at the start and end of the study, where
relevant records (eg, the reasons for losses) might or
might not be available. Reporting the approach used
by the authors to minimize loss to follow-up will
allow users to assess the potential for bias related to
this loss.
6(d) For Matched Studies, Describe Matching
Criteria and Number of Matched Individuals per
Subject (eg, Number of Controls per Case)
Example 1
Two to 4 control farms matched to each case farm
on the basis of type of farm (dairy or beef) and loca-
tion (inside or outside the TB core area) were
included in the study.33
Example 2
Each time a herd was recorded as a ‘case’, a ran-
domly selected at-risk herd was identiﬁed as a
‘control’. Each control herd was selected with
probability proportional to their time at risk (inci-
dence density sampling) during the study peri-
od. . .34
Explanation
Matching is more common in case-control studies,
but occasionally, investigators use matching in cohort
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studies. Matching in cohort studies makes groups
directly comparable for potential confounders (Box 5:
Confounding) and presents fewer intricacies than with
case-control studies. For example, it is not necessary to
take the matching into account for the estimation of the
relative risk. Because matching in cohort studies might
increase statistical precision, investigators might allow
for the matching in their analyses and thus obtain nar-
rower conﬁdence intervals.
In case-control studies, matching is done to increase
a study’s eﬃciency by ensuring similarity in the distri-
bution of variables between cases and controls, in par-
ticular the distribution of potential confounding
variables.35,36 Example 1 illustrates this type of match-
ing description by matching on farm type and loca-
tion. Because matching can be done in various ways,
with one or more controls per case, the rationale for
the choice of matching variables and the details of the
method used should be described. Commonly used
forms of matching are frequency matching (also called
group matching) and individual matching. In fre-
quency matching, investigators choose controls so that
the distribution of matching variables becomes identi-
cal or similar to that of cases. Individual matching
involves matching one or several controls to each case.
Matching is not always appropriate in case-control
studies, but if used, it needs to be taken into account
in the analysis (see Box 2: Matching in case-control
studies).
Although matching is generally considered to be
based on potentially confounding population character-
istics, in some case-control studies, the term matching is
also used to describe a means of controlling selection
from the risk set based on the case occurrence timing
such as in an incidence density sampling design. Exam-
ple 2 provides a description of a time-matched selection
control approach.
7(a) Clearly Deﬁne all Outcomes, Exposures,
Predictors, Potential Confounders, and Eﬀect
Modiﬁers. If Applicable, Give Diagnostic Criteria
Example 1
. . .the explanatory variable of interest was IBK status.
Other explanatory variables included in each model as
potential eﬀect modiﬁers or confounders of the associ-
ation between IBK and weight at ultrasonographic
evaluation were birth weight, season, sex of calves
after weaning (bull, heifer, or steer), ADG (weaning to
yearling weight), preweaning management group,
postweaning management group, year of calving, sea-
son of calving, the interaction between year and sea-
son, and age at ultrasonographic evaluation37
Example 2
Refer to Section 6(c) for a good description of the
outcome event(s) in a cohort study.
Example 3
Body condition was scored from 1 (emaciated) to 5
(obese) using standard methods described by DAFF
[]. Faecal consistency was scored as described by
Alberta Dairy Management [] from 1, representing a
liquid consistency, to 4, representing a dry sample.
Hide cleanliness was scored following the guidelines
of the Food Standards Agency [], where 1 = clean
and dry, and 5 = ﬁlthy and wet.38
Explanation
Authors should deﬁne all variables considered for
and included in the analysis, including outcomes,
Box 1 Bias in Observational Studies
Bias is a systematic deviation of a study’s results from a true value. Typically, it is introduced during the design or
implementation of a study and its eﬀects cannot be eliminated later or correct analytically. Bias and confounding
are not synonymous. Bias arises from ﬂawed information or subject selection so that a wrong association is found.
Confounding produces relations that are factually correct, but they cannot be interpreted causally because some
underlying, unaccounted for factor is associated with both exposure and outcome (see Box 5: Confounding). Bias
diﬀers from random or chance error such as a deviation from a true value caused by random ﬂuctuations in the
measured data in either direction. Many potential sources of bias have been described and a various terms have
been used.132 We ﬁnd that it is helpful to separate them into two simple categories: information bias and selection
bias.
Information bias occurs when systematic diﬀerences in data completeness or accuracy lead to animal misclassiﬁca-
tion with respect to exposures, outcomes, or measurement errors of values recorded on a continuous scale. Detec-
tion bias in cohort studies, interviewer bias, and recall bias are all forms of information bias. For example, in a
case-control study of risk factors for horse falls, poor dressage performers were less likely to report accurate dres-
sage scores than good performers, thereby introducing information bias.133
Selection bias exists when the association between the exposure and outcome among study-eligible participants is
diﬀerent from those participants included at any stage of the study, from entry to the study to inclusion in the anal-
ysis. Various types of selection bias include bias introduced when selecting the control group in a case-control
study, diﬀerential loss to follow-up, incidence-prevalence bias, volunteer bias, healthy worker bias, and nonresponse
bias.134 Detection bias also acts as a form of selection bias in case-control studies.135
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exposures, predictors, potential confounders, and poten-
tial eﬀect modiﬁers. Disease outcomes require ade-
quately detailed description of the diagnostic criteria.
This applies to criteria for cases in a case-control study,
disease events during follow-up in a cohort study, and
prevalent disease in a cross-sectional study.
We advise that authors should declare all “candidate
variables” considered for statistical analysis, rather than
selectively reporting only those included in the ﬁnal
models (see also item 16a).39,40 Authors should report
whether exposures are consistent or change over the
study period. For studies involving follow-up, authors
should describe how study subjects were uniquely iden-
tiﬁed, allowing research personnel to correctly record
observations at follow-up visits.
7(b) Describe the Level of Organization at Which
Each Variable was Measured
Example
Fixed explanatory variables considered for inclusion
in the PA-MNT model were assessment day (d –4,
+1, +3, +6, +8, and +10), eye-level IBK-associated
corneal ulceration status (present or absent), calf-
level IBK-associated corneal ulceration status (pre-
sent or absent), and landmark (7 levels).41
Explanation
Animal populations commonly have multiple organi-
zational levels, so authors should clarify the organiza-
tional level at which each variable was measured. For
more information, see Box 4: Organization structures in
animal populations.
7(c) For Hypothesis-Driven Studies, the Putative
Causal Structure Among Variables Should be
Described (A Diagram is Strongly Encouraged)
Example
Causal diagrams were constructed to describe postu-
lated links between measured exposure variables and
between exposure variables and occurrence of BRD
in the ﬁrst 50 days at risk. As this resulted in a very
complex diagram, a simpliﬁed version (only including
variables relevant to the assessment of the risk fac-
tors included in the analyses reported in this paper)
is shown in Fig. 1. Figure 2 shows the causal dia-
gram used to inform the analyses restricted to the
three feedlots that routinely used pre-induction
assembly. Additional variables included as potential
confounders in either of these diagrams were cohort
ﬁll duration (all animals added to their cohort within
a single day or over a longer period), total number
of animals on feed in the animal’s feedlot (average
for the animal’s induction month), number of ani-
mals in the animal’s cohort, induction weight, breed
and season in which the animal was inducted. . . .The
DAGitty software [] was used to identify minimal
suﬃcient adjustment sets to assess total and direct
eﬀects of the exposure variable of interest on the
occurrence of BRD.
Figures extracted from publication42
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Explanation
For hypothesis-driven studies, it is extremely useful
to the end user if the a priori hypothesis and the vari-
able relationships envisioned by the authors are clear
and understandable. There are various means available
for articulating causal assumptions,43 including directed
acyclic graphs (DAGs).44 Including a causal assumption
diagram is strongly recommended. Understanding the
underlying causality being explored is important when
identifying potential confounding variables and inter-
preting the results of multivariable analyses. If variables
are controlled unnecessarily in a regression model, the
power is reduced, and the association between the expo-
sure of interest and the outcome might be biased.43,45,46
8(a) For Each Variable of Interest, Give Sources
of Data and Details of Methods of Assessment
(Measurement). If Applicable, Describe
Comparability of Assessment Methods Among
Groups and Over Time
Example
Each tumour was examined independently by two spe-
cialist veterinary pathologists and, to be included, had
to have a minimum of 7 (out of a possible 10) features
identiﬁed as part of the histopathology study. The 10
features included the presence of: aggregates of lym-
phocytes, inﬁltrative margins, intralesional necrosis,
perilesional scarring,/inﬂammation, adjuvant-like
material in macrophages, medium-high mitotic rate,
giant cells and types of cellular diﬀerentiation []. To be
included in the estimate of incidence the FISS (‘Feline
Injection Site Sarcomas’ added by authors) had to be
diagnosed at the practices for which denominator
information was available.47
Explanation
The way in which exposures, confounders, and out-
comes were measured aﬀects the reliability and validity
of a study. Measurement error and misclassiﬁcation of
exposures or outcomes can make it more diﬃcult to
detect cause-eﬀect relationships, or might produce spuri-
ous relationships. Error in measurement of potential
confounders can increase the risk of residual confound-
ing.48,49 It is helpful, therefore, if authors report the
ﬁndings of any studies of the validity or reliability of
assessments or measurements, including details of the
reference standard that was used. Rather than simply
citing validation studies, we advise that authors give the
estimated validity or reliability, which can then be used
for measurement error adjustment or sensitivity analy-
ses (see items 12 and 17).
Box 2 Matching in Case-Control Studies
In any case-control study, choices need to be made on whether to use matching of controls to cases, and if so, what
variables to match on, the precise method of matching to use, and the appropriate method of statistical analysis.
Although confounding can be adjusted for in the analysis, there could be a major loss in statistical eﬃciency. The
use of matching in case-control studies and its interpretation are fraught with diﬃculties, especially if matching is
attempted on several risk factors, some of which might be linked to the exposure of prime interest.27,136 For exam-
ple, in a case-control study of a Salmonella outbreak, investigators could match based on factors, such as sex, that
are related to the consumption of various food products. However, this control group would no longer represent
food consumption choices in the general population and has several implications. A crude analysis of the data will
produce odds ratios that are usually biased toward unity if the matching factor is associated with the exposure. The
solution is to perform a matched or stratiﬁed analysis (see item 12d). In addition, because the matched control
group ceases to be representative for the population at large, the exposure distribution among the controls can no
longer be used to estimate the population attributable fraction (see Box 6: Measures of Association and measures
of impact).137 Also, the eﬀect of the matching factor can no longer be studied. If matching is done on multiple fac-
tors, the search for well-matched controls can be cumbersome and a nonmatched control group might be prefer-
able.
Overmatching is another problem, which might reduce the eﬃciency of matched case-control studies and, in some
situations, introduce bias.
Information is lost and the power of the study is reduced if the matching variable is closely associated with the
exposure. Then, many individuals in the same matched sets will tend to have identical or similar levels of exposures
and therefore not contribute relevant information.
The complexities involved with matching have caused some methodologists to advise against routine matching in
case-control studies. Instead, they recommend judicious consideration of each potential matching factor, recogniz-
ing that it could potentially be measured and used as an adjustment variable. As a result, studies are reducing
the number of matching factors employed, and increasing the use of frequency matching, which avoids some of
the problems discussed above. In addition, case-control studies are increasingly abandoning potential confounder
matching.138 Currently, matching remains advisable, or even necessary, when confounder distributions diﬀer radi-
cally between the unmatched comparison groups (eg, age).35,36
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In addition, it is important to know if groups being
compared diﬀered with respect to the way in which the
data were collected. For instance, if an interviewer ﬁrst
questions all the cases and then the controls, or vice
versa, bias is possible because of the learning curve;
solutions such as randomizing the order of interviewing
might avoid this problem. Information bias might also
arise if the compared groups are not given the same
diagnostic
8(b) If a Questionnaire was Used to Collect
Data, Describe Its Development, Validation, and
Administration
Example
Questionnaire designs were the collective eﬀort of
ﬁve veterinarians (including four epidemiologists)
and a biostatistician. Included in the design group
was the Veterinary Oﬃcer for Poultry Diseases, who
had an in-depth knowledge of each farm as a result
of working with the producers to eradicate Sal-
monella from poultry. There were several question-
naires, the main one designed to record independent
variables acting at the various levels of broiler pro-
duction such as at the ﬂock, house and farm levels.
During the interval between ﬂocks in each broiler
house, a ﬁeld technician employed by the Veterinary
Oﬃcer for Poultry Diseases visited each farm to
record responses from face-to-face interviews with
the person most closely associated with the hands-on
management of the broiler ﬂocks and houses, and to
record observations of cleaning and disinfection pro-
cedures between ﬂocks. The design team reviewed all
questions and the method of recording with the ﬁeld
technician to ensure clear understanding. The Veteri-
nary Oﬃcer for Poultry Diseases accompanied the
ﬁeld technician on all farm visits and questionnaire
recording for the ﬁrst full month of sampling. Dur-
ing the course of the study, two university-educated
ﬁeld technicians were employed. The ﬁrst technician
was employed for 2 years, and trained the second
technician for 1 month prior to leaving the project.
Interview times varied from 10 to 15 min per ques-
tionnaire, depending on whether the producer needed
to verify records. To ensure consistency in responses,
data collected at the previous visit were reviewed
with the producer. All questions pertaining to our
analysis were closed.50
Explanation
For STROBE-VET, we needed to draw attention to
the descriptions of questionnaire development and
administration, because questionnaires are a common
data source for veterinary observational studies. Occa-
sionally, authors provide information documenting
their questionnaire validation methods, sometimes as a
separate publication.51,52 If previous validation infor-
mation is not available, then the authors should
describe their approach for developing and testing the
questionnaire in the manuscript. Like any diagnostic
test, unless validated, the diagnostic characteristics of
the questionnaire and its ability to accurately measure
the variables are unclear. The questionnaire(s) should
also be included as supplementary data, or in an open
access, permanent site preferably with a digital object
identiﬁer (DOI).
8(c) Describe Whether or Not Individuals
Involved in Data Collection were Blinded, When
Applicable
Example
This was an observational study of 292 uniquely
identiﬁed Bovelder cows born in either 2002 or 2003
(2002 and 2003 cohorts) that were followed from just
prior to their ﬁrst breeding season until they had
weaned up to ﬁve calves. . . . Farm management and
staﬀ were blinded to RTS (reproductive tract scor-
ing) data throughout the study.53
Explanation
Although blinding is commonly associated with ran-
domized controlled trials, in observational studies, there
is potential for information bias in measurement of
exposure arising from knowledge of the outcome of
interest (case-control studies) or information bias in
measurement of the outcome arising for knowledge of
the exposure of interest (cohort studies).3,4 For exam-
ple, if researchers conduct a case-control study deter-
mining factors associated with a tick-borne disease such
as Lyme disease (the outcome of interest) and an owner
is interviewed about indoor or outdoor exercise (the
exposure of interest), the owners of case animals might
recall outdoor exercise more easily, because they are
familiar with the disease and its causes. This prior
knowledge is a potential source of bias. Thus, informa-
tion about blinding is critical for the reader to assess
the impact of bias on the study result. Similar to clini-
cal trials, the use of the terms single and double blind-
ing should be avoided. Rather, the author should
specify the task, caregiver, or outcome assessor who is
blinded.54
8(d) Describe Any Eﬀorts to Assess the Accuracy
of the Data (Including Methods Used for “Data
Cleaning” in Primary Research, or Methods
Used for Validating Secondary Data)
Example
Selections of dogs from the entire hospital records
were made using Oracle programming languages . . . [].
First, an in-house hospital code for laboratory-con-
ﬁrmed diagnosis of urolithiasis was used to isolate all
the eligible dogs within the boundaries of the study
population. . . . Afterwards, urolith laboratory results
or medical notes of the identiﬁed dogs were manually
reviewed to isolate those whose urolith composed of
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at least 70% monohydrate or dehydrate forms of
CaOx (case dogs). Urolith composition was deter-
mined at one of two commercial laboratories . . . by
means of optical crystallography or infrared spec-
troscopy as described elsewhere [].55
Explanation
Reporting the measurement approach is frequently
insuﬃcient to ensure validity; therefore, when eﬀorts
are made to ensure the data are valid (eg, the case
validity in the example above), these methods should be
documented. This documentation enables the end user
to identify potential information bias. In the example
above, there could have been concern that the electronic
medical records were inaccurate; therefore, the authors
validated the electronic medical records by examining
the physical medical records, giving the end user greater
conﬁdence in the variable measured. In addition, when
data are used for multiple diﬀerent studies, the data
could have been collected for a diﬀerent purpose ini-
tially than that described in the later study. In this case,
the original purpose should be described. A description
of data validation approaches has recently been pub-
lished.56
9 Bias: Describe Any Eﬀorts to Address Potential
Sources of Bias Due to Confounding, Selection,
or Information Bias
Example
The responses were collected through face-to-face
interviews conducted by four experienced interview-
ers (two teams each comprising two interviewers)
between October 2011 and March 2012. As there are
diﬀerent dialects in the Philippines, the questionnaire
was written in English and translated to the appro-
priate dialect at the interview. To reduce informa-
tion bias the questionnaire was pretested on experts
in the Philippines pig production systems comprising
regional and provincial veterinary oﬃcers and ani-
mal health advisors. All questions in the question-
naire were clariﬁed with all interviewers before the
study date. The interviewers were instructed to ask
questions exactly as stated in the questionnaire and
provide only non-directive guidance. To minimize
inter-observer variability in conducting the interview,
all observers and PVO [Provincial Veterinary Oﬃce]
personnel met after the questionnaire was piloted on
the six farms to agree on a common interpretation
of the ﬁndings. If there was disagreement, the inter-
pretation of the PVO was chosen. To minimize
information (misclassiﬁcation) and selection biases,
the interviewers were asked to verify the trader’s
identity, dates when the pigs were sold and number
of pigs sold for slaughter before an interview was
conducted. . . . The validity of the collected question-
naire data was conﬁrmed during follow-up visits to
six farms (three in each province) by the ﬁrst author,
the interviewers and Provincial Veterinary Oﬃcers
personnel. To reduce misclassiﬁcation bias that
could arise from coding errors, the interviewers and
the ﬁrst author checked and corrected impossible
coding of categorical variables (n = 80) and unreli-
able outlier values for continuous variables
(n = 3).57
Explanation
Bias causes study results to diﬀer systematically from
the truth. It is important for a reader to know what
measures were taken during the conduct of a study to
reduce the potential of bias. Ideally, investigators care-
fully consider potential sources of bias when they plan
their study. At the stage of reporting, we recommend
that authors always assess the likelihood of relevant
biases. Speciﬁcally, the direction and magnitude of bias
should be discussed and, if possible, estimated. When
investigators have set up quality control programs for
data collection to counter a possible “drift” in measure-
ments of variables in longitudinal studies, or to keep
variability at a minimum when multiple observers are
used, these should be described. In veterinary medicine,
euthanasia or animal culling is a unique potential form
of attrition bias, and authors should describe any meth-
ods used to account for this bias. Recently, an overview
of approaches for addressing bias, including quantita-
tive bias analysis and the use of bias parameters in data
analysis, with accompanying veterinary examples was
published.58
A discussion about selection bias, information bias,
and confounding as well as their impact on observa-
tional studies is provided in Box 1: Bias in observa-
tional studies and Box 5: Confounding.
10(a) Study Size: Describe How the Study Size
was Arrived at for Each Relevant Level of
Organization
Example
A sample size of 36 cases and 108 controls was cal-
culated to provide a 95% level of conﬁdence for
detecting an odds ratio of 3 with 80% statistical
power, assuming a 1:3 ratio of case to control farm-
ers and a random notiﬁcation process such as a 50%
probability of reporting observed oyster mortality.
Sample size was increased by 15% to account for
non-participation rate observed in previous and
recent studies conducted in the same population [],
leading to a total of 41 cases and 124 controls, out
of 165 and 703 eligible oyster farmers, respectively.59
Explanation
A study should be large enough to obtain a point esti-
mate with a suﬃciently narrow conﬁdence interval to
meaningfully answer a research question. Large samples
are needed to distinguish a small association from no
association. Small studies often provide valuable
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information, but wide conﬁdence intervals might indicate
that they contribute less to current knowledge in compar-
ison with studies providing estimates with narrower con-
ﬁdence intervals. Also, small studies that show
“interesting” or “statistically signiﬁcant” associations are
published more frequently than small studies that do not
have “signiﬁcant” ﬁndings. Although these studies might
provide an early signal in the context of discovery, read-
ers should be informed of their potential weaknesses.
The importance of sample-size determination in
observational studies depends on the context. If an
analysis is performed on data that were already avail-
able for other purposes, the main question is whether
the analysis of the data will produce results with suﬃ-
cient statistical precision to contribute substantially to
the literature. Formal a priori calculation of sample size
might be useful when planning a new study.60,61 Such
calculations are associated with more uncertainty than
implied by the single number that is generally produced.
For example, estimates of the rate of the event of inter-
est or other assumptions central to calculations are
commonly imprecise, if not guesswork.62 The precision
obtained in the ﬁnal analysis can often not be deter-
mined beforehand because it will be reduced by inclu-
sion of confounding variables in multivariable
analyses,63 the degree of precision with which key
variables can be measured, and the exclusion or nonse-
lection of some individuals.64
Sample-size determination can be complicated further
by studies with multiple objectives. Studies frequently
have multiple objectives, largely to maximize the
amount of data that can be collected from a research
study. For instance, a cross-sectional study might esti-
mate an outcome frequency and evaluate the associa-
tion between one or more exposures on that outcome.
It should be clear to the reader which objective was
used for sample-size determination or, if both objectives
were considered, how the ﬁnal sample size was derived.
In animal health, observational studies might not be
hypothesis-driven. These studies are not conducted to
detect a speciﬁc eﬀect size magnitude for an a priori
identiﬁed exposure of interest. Instead, a large number
of association measures are calculated with varying
levels of precision. This type of study is hypothesis gen-
erating. This factor should be discussed speciﬁcally, and
the rationale for the sample size should be provided.
Often, studies do not use formal sample-size calcula-
tions. For example, when a small number of cases are
available for a case-control study, the investigators
might choose to include all eligible cases. In this case,
the reader still needs to understand how the sample size
was derived such as selection of all available cases to
Box 3 Grouping/Categorization
There are several reasons why continuous data might be grouped. 139 When collecting data, it might be better to
use an ordinal variable than to seek an artiﬁcially precise continuous measure for an exposure based on recall over
several years. Categories might also be helpful for presentation, for example, to present all variables in a similar
style, or to show a dose-response relationship.
Grouping might also be done to simplify the analysis, for example, to avoid an assumption of linearity or when
investigating interactions between two continuous variables. However, grouping loses information and might reduce
statistical power140 especially when dichotomization is used.69,141,142 If a continuous confounder is grouped, residual
confounding might occur, whereby some of the variable’s confounding eﬀect remains unadjusted (see Box 5: Con-
founding).48,143 Increasing the number of categories can diminish power loss and residual confounding, and is espe-
cially appropriate in large studies. Small studies might use few groups because of limited numbers.
Investigators might choose cut points for groupings based on commonly used values that are relevant for diagnosis
or prognosis, for practicality, or on statistical grounds. They might choose equal numbers of individuals in each
group using quantiles.144 On the other hand, one might gain more insight into the association with the outcome by
choosing more extreme outer groups and having the middle group(s) larger than the outer groups.145 In case-con-
trol studies, deriving a distribution from the control group is preferred because it is intended to reﬂect the source
population. Readers should be informed if cut points were selected post hoc. In particular, if the cut points were
chosen to minimize a P-value, the true strength of an association will be exaggerated.68
When analyzing grouped variables, it is important to recognize their underlying continuous nature. For instance, a
possible trend in risk across ordered groups can be investigated. A common approach is to model the rank of the
groups as a continuous variable. Such linearity across group scores will approximate an actual linear relation if
groups are equally spaced but not otherwise. Il’ysova et al146 recommend publication of both the categorical and
the continuous estimates of eﬀect, with their standard errors, to facilitate meta-
analysis, as well as providing intrinsically valuable information on dose-response. One analysis might inform the
other and neither is assumption-free. Authors often ignore the ordering and consider the estimates (and P-values)
separately for each category compared to the reference category. This might be useful for description, but might fail
to detect a real trend in risk across groups. Recent method developments, such as fractional polynomials that ﬁt a
wide range of nonlinear relationships,147 and the availability of software to implement these methods in standard
software packages reduce the need to routinely categorize variables.
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evaluate the potential for selection bias or identify an
underpowered study.
10(b) Describe How Nonindependence of
Measurements was Incorporated into Sample-Size
Considerations, If Applicable
Example 1
The expected prevalence of MRSA was estimated to
be considerably lower at 1–2% [], with a much lower
between cluster T variance estimated at 0.0001,
meaning a total of 800 nasal swab samples would be
required to estimate prevalence with a precision of
1% and 95% conﬁdence. To allow for an overall
compliance proportion of approximately 60%, each
practice was asked to recruit the next 20 horses seen
on visits (a total of 1,300 horses).65
Example 2
Researchers adjusted this sample size for clustering
of stillbirth risk in a herd by using the formula n* = n
[1 + (m  1)p], where m is the average herd size, p is
the intra- class correlation coeﬃcient (ICC), and n is
the unadjusted sample size necessary to determine the
diﬀerence between 2 proportions. Expected herd size
was approximately 150 cows and the ICC was esti-
mated to be 0.09.66
Explanation
Given the frequency of nonindependent study units in
animal populations (see Box 4: Organization structures in
animal populations), authors should adjust sample-size
calculations to account for nonindependence. Failure to
account for nonindependence in sample-size determina-
tions might result in studies that are underpowered when
analyzed correctly using methods that account for cluster-
ing. The ethics of conducting underpowered studies are
less obvious for observational studies, because study units
are observed rather than purposefully assigned to a group.
However, resources are potentially wasted when studies
are underpowered; therefore, adjustment for nonindepen-
dence in sample-size determinations should be conducted
for prospectively planned observational studies.
10(c) If a Formal Sample-Size Calculation was
Used, Describe the Parameters, Assumptions, and
Methods that were Used, Including a Justiﬁcation
for the Eﬀect Size Selected
Example
. . .prior to conducting the analysis, sample size calcu-
lations were performed to determine whether it was
likely to obtain a data set of suﬃcient size to detect a
diﬀerence of 7.5 kg (16.5 lb) in the primary outcome,
live weight, in a population with 33% of calves in the
IBK group and 67% in the unaﬀected group, with a
type I error probability of 0.05, a type II error proba-
bility of 0.8, and a 1:2 ratio for case and control
calves. The rationale for use of these parameters was
that results of a prior study suggested that calves with
IBK weighed approximately 7.5 kg less at weaning
than unaﬀected calves, and the prevalence of IBK was
approximately 33% in the study herd.37
Explanation
Samples sizes should be calculated based on realistic
estimates. Although statistical power can be determined
using the eﬀect estimate precision and low power aﬀects
precision not bias, providing the rationale and assump-
tions used in the calculations allows the reader to infer
the impact of those assumptions on the sample size.
For example, what constitutes a meaningful diﬀerence
might vary between diﬀerent regions, and the assumed
level of nonindependence can vary between populations.
11 Quantitative Variables: Explain How
Quantitative Variables were Handled in the
Analyses. If Applicable, Describe Which
Groupings were Chosen, and Why
Examples
Age was grouped on a biological basis into less than
2.5 years, between 2.5 and 4.5 and >4.5 years. This
categorisation was decided upon as 2.5 and 4.5 years
approximately coincide with ages at ﬁrst and second
parturition in llamas.67
Explanation
Investigators make choices regarding how to collect
and analyze quantitative data about exposures, eﬀect
modiﬁers, and confounders. Grouping choices might
have important consequences for later analyses.68,69 We
advise that authors explain why and how they grouped
quantitative data, including the number of categories,
the cut points, and category mean or median values (as
appropriate). Whenever data are reported in tabular
form, the counts of cases, noncases or controls, animals
at risk, animal time at risk, etc. should be given for
each category. Tables should not consist solely of eﬀect-
measure estimates or results of model ﬁtting. Authors
should state whether categories were selected a priori or
based on the collected data.
Investigators might model an exposure as continuous to
retain all the information. In making this choice, one needs
to consider the nature of the relationship of the exposure
to the outcome. Investigators should report how depar-
tures from linearity were investigated, for example, using
log transformation, quadratic terms, or spline functions.
Several methods exist for ﬁtting a nonlinear relation
between the exposure and outcome.69–71 Also, it might be
informative to present both continuous and grouped anal-
yses for a quantitative exposure of prime interest.
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Box 4 Organization Structures in Animal Populations
Many animal populations occur in organizational structures, which results in individual animals (or groups of ani-
mals) not being independent from one another.4,148 These organizational structures might be hierarchical, such as
those related to housing (animals within barns, barns within farms, farms within production systems, production
systems within regions) or genetics (piglets within sows, calves within dams, daughters within sires). Animal popula-
tions can also be nonindependent but not hierarchical. For example, beef calves from several cow-calf farms might
be transported to multiple feedlots, where calves from multiple farms commingle in pens. Calves from the same
farm or housed in the same pen or feedlot probably have more exposures in common than calves at a diﬀerent
farm or in a diﬀerent pen or feedlot. Such organizational structures imply nonindependence, which will inﬂuence
the actual number of observational units in the study and power in the statistical analyses. Therefore, the noninde-
pendence must be accounted for in the study design or adjusted for in the data analysis.149
Further, the study’s end users might be interested in diﬀerent hierarchy levels. Thus, it is essential that the
authors clearly state what level is being studied. For example, for a particular disease, producers and veterinari-
ans might focus on the disease prevalence within herds and factors associated with individual risk of developing
disease.150 However, company oﬃcials might be interested in the prevalence of positive herds within a production
system and factors associated with a herd being positive or with high or low prevalence.150 Government oﬃcials
might concentrate on diﬀerences in the prevalence of positive herds across regions of a country or among coun-
tries. It is also possible to report the outcomes of interest at diﬀerent organizational structure levels in a single
study.151–153 Given this complexity, authors must ensure that readers are aware of the organizational level(s) that
exist within the study population and the level at which variables are measured and summarized. This informa-
tion allows the reader to (1) decide whether the paper is of interest and (2) assess experimental approaches for
biases, which might diﬀer based on the hierarchy level summarized. A diagram showing the organizational struc-
ture might be helpful to convey this information.
The organizational structure is relevant to numerous parts of a publication. In particular, we advise providing
information about the study population’s organizational structure in items 3, 6, 7, 12, 13, 14, and 15. Here, we
provide two study examples along with a description of how to report organization structures in items 3, 6, 7,
and 12.
Example 1. A Hypothetical Multiclinic Study of Demographic Factors Aﬀecting Survival of dogs with Osteosar-
coma
Item 3 would describe the study objective: to understand demographic factors that impact a dog’s survival time.
For this theoretical example, the hypothesis is that dog age is associated with reduced survival time in individual
dogs.
Item 5 would describe the clinics and clinicians participating in the study and indicate that they are a likely source
of nonindependence.
Item 6 would describe the eligibility criteria for selecting clinics, clinicians, and clients and dogs for the study.
Item 7 would deﬁne the outcome and other variables, as well as the organizational level for each variable. For this
hypothetical example, the measurement level for the outcome was at the individual level such as a dog’s survival
time. The exposure factors of interest were also at the individual level such as the dog age, dog weight, and dog
breed.
Item 8 would describe how each of the variables listed in item 7 was measured and state that all of these measure-
ments were performed at the individual level (the dog level).
Item 12 would describe how the analysis approach accounted for the impact of the organization structure such as
dog nonindependence, nested within clinics and clinicians.
Example 2. A Hypothetical Multifarm Study of Factors Aﬀecting the Prevalence of Salmonella in Swine Barns
Item 3 would describe the study objective: to understand barn-, site-, and company-level characteristics associated
with the prevalence of Salmonella in swine barns. In the example study, the hypothesis was that the prevalence of
Salmonella is higher in barns where birds are observed.
Item 5 would state that the pigs are nested within barns, the barns are nested within sites, and the sites within com-
panies. Other possible sources of nonindependence (eg, if farms are nested geographically) should also be stated.
Item 6 would describe the criteria for selecting the companies, the sites within each company, the barns within each
site, and the pigs within each barn. It would include at what organizational levels, convenience sampling was used.
For example, in our hypothetical study, researchers used a relationship with a production company to gain access
to a production site. They also used convenience to decide which production sites to study and selected all barns
on each site to be surveyed. Then, they randomly selected 30 pigs within each barn to obtain barn-level estimates
of Salmonella prevalence.
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12 Statistical Methods
12(a) Describe All Statistical Methods for Each
Objective, at a Level of Detail Suﬃcient for a
Knowledgeable Reader to Replicate the Methods.
Include a Description of the Approaches to
Variable Selection, Control of Confounding, and
Methods used to Control for Nonindependence of
Observations
Example 1
Collinearity between the variables was investigated
by v2 analysis. The risk factors initially oﬀered to
the model were excluded from the model with a con-
ditional backward elimination procedure; the possi-
ble interaction terms were then investigated with a
forward conditional selection procedure. A factor
was entered in the model at P ≤ .05 and removed at
P ≥ .10. The likelihood ratio test was used to assess
the overall signiﬁcance of the model (two-tailed sig-
niﬁcance level P ≤ .05). Confounding was monitored
by evaluating the change in the coeﬃcient of a factor
after removing another factor; if the change exceeds
25% of the coeﬃcient value, the removed factor is
considered a potential confounder. The signiﬁcance
of each term in the model was tested by Wald’s v2.
In the ﬁnal model, biologically plausible interaction
between factors was investigated by signiﬁcance.
Estimated OR and 95% Wald’s conﬁdence interval
(CI) were obtained as measures of predictor eﬀect.72
Example 2
To account for the hierarchical structure of the data, a
cross-classiﬁcation of feedlot-years (11 feedlots in
2000, 13 in 2001–2002. . .) was included as a random
intercept to model the overdispersion arising from the
lack of independence of cohorts nested within feedlots,
and of feedlots nested within arrival years. In addi-
tion, arrival month . . . was modeled as a random
intercept using a ﬁrst-order autoregressive covariance
structure to account for the repeated measures of
cohorts, within feedlot-years, over months with decay
in correlation with increasing distance between obser-
vations [] Lastly, arrival week . . . within a month was
modeled as a random intercept to control for the cor-
relation of weeks within arrival months.73
Explanation
Describing statistical methods can be challenging,
because the level of detail suﬃcient for a knowledgeable
reader to replicate the methods is open to interpretation.
(http://cdn.elsevier.com/promis_misc/AMEPRE_gfa_mar
2015.pdf). The author should focus on clearly describing
the approach rather than listing statistical tests. Inclusion
of a diagram or ﬂowchart to explain a complex analytical
process might be helpful. One applicable resource for
reporting statistical methods are the SAMPL guide-
lines.74 Based on the SAMPL guidelines, the description
of the analysis approach can be split into three components:
(1) the preliminary analysis, (2) the primary analysis, and
(3) any supplementary analysis. Authors are encouraged to
make the data and their software coding available as sup-
plementary material or in data depositories.
In general, there is no one correct statistical analysis
but, rather, several possibilities that might address the
same question, but make diﬀerent assumptions. Regard-
less, investigators should predetermine analyses at least
for the primary study objectives in a study protocol.
Often additional analyses are needed, either instead of,
or as well as those originally envisaged, and these might
sometimes be motivated by the data. Authors should
Item 7 would deﬁne the outcome and other variables, ensuring the organizational level is stated clearly. For this
study, the outcome of interest was the prevalence of Salmonella in each barn. The exposure variables of interest
were feed type (a site-level variable), and potential confounders included the feed mill used (a site-level variable)
and the presence of birds in barns (a barn-level variable).
Item 8 would describe how each of the variables deﬁned in item 7 was measured. In this study, it would be impor-
tant to clarify that Salmonella status was measured in pigs (an individual-level variable) and the prevalence was
summarized as a proportion, so it could be expressed as a barn-level outcome. The laboratory approach for deter-
mining Salmonella status should be described here. This item should state that data regarding the feed mills used
at each site were obtained from company records and the presence of birds was determined using a questionnaire
administered to the site manager. The validity of that questionnaire should be described as a component of this
item.
Item 12 would describe how the analysis approach accounted for the organizational structure such as nonindepen-
dence of barns within farms, farms within regions, farms within the production system. Because the outcome was
measured at the barn level (as clariﬁed in item 7), authors would need to account for the clustering of pigs within
barns.
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tell readers whether particular analyses were suggested
by data inspection. Even though the distinction between
prespeciﬁed and exploratory analyses might sometimes
be blurred, authors should clarify reasons for particular
analyses.
Authors should explain all potential confounders
considered, and the criteria for excluding or including
variables in statistical models. Decisions about exclud-
ing or including variables should be guided by knowl-
edge, or explicit assumptions, on causal relations.
Inappropriate decisions might introduce bias, for exam-
ple, by including variables that are in the causal path-
way between exposure and disease (unless the aim is to
assess how much of the eﬀect is carried by the interme-
diary variable). If the decision to include a variable in
the model was based on the change in the estimate, it
is important to report what change was considered suf-
ﬁciently important to justify its inclusion. If an algo-
rithm such as “backward elimination” or “forward
inclusion” was used, report the process (including
whether a manual or automated process was used) and
the signiﬁcance level and test or other basis (informa-
tion criteria) for selecting inclusion or exclusion of
variable(s) from the model.
12(b) Describe the Rationale for Examining
Subgroups and Interactions and the Methods
Used
Example
Biologically important two-way interactions of the
explanatory variables in the ﬁnal model were exam-
ined and retained if signiﬁcant (P < .05).75
Explanation
Subgroup analyses and interactions can be planned
or conducted after reviewing the data. Authors should
report if the subgroup analysis was preplanned or
informed by data examination. This information allows
the end user to identify the presented associations in the
context of hypothesis testing or hypothesis generating.
12(c) Explain How Missing Data were Addressed
Examples
In model 1, only subjects with complete information
on variables in the ﬁnal model were included. Model
2 was a Bayesian full-likelihood analysis where
Box 5 Confounding
Confounding literally means the confusion of eﬀects. A study might seem to show either an association or no asso-
ciation between an exposure and the risk of a disease. In reality, the seeming association or lack of association is
due to another factor that determines the occurrence of the disease but that is also associated with the exposure.
The other factor is called the confounding factor or confounder. Confounding thus gives a wrong assessment of the
potential “causal” association of an exposure. For example, an apparent positive association between dogs attend-
ing obedience classes and dog bites could occur if speciﬁc, large-breed dogs that are prone to biting were more
likely to attend the observed obedience classes. In this instance, breed would confound the relationship between
obedience class attendance and biting.
Investigators should think beforehand about potential confounding factors, a process that could be enhanced by
constructing a causal diagram (see item 7c). An a priori consideration of potential confounding variables will
inform the study design and allow proper data collection by identifying the confounders for which detailed infor-
mation should be sought. Restriction, matching, or analytical adjustment might also control confounding. In the
example above, the study might be restricted to speciﬁc breeds. Matching on breed might also be possible, although
not necessarily desirable (see Box 2: Matching in case-control studies). There are a number of analytic approaches
for identifying confounding variables, which can be broadly grouped into knowledge-based and statistical.154,155
Many of the approaches for controlling confounding assume that the investigator has one or more exposures of
interest identiﬁed a priori. In veterinary literature, observational studies commonly identify risk factors for an out-
come from an array of possible independent variables with no a priori identiﬁcation of an exposure of interest or
causal diagram.
Regardless of the approach used, when variables are selected for model inclusion, the interpretation of each associ-
ation needs to be evaluated post hoc to evaluate whether all important confounders for that association were
included. As part of the post hoc assessment, authors should consider whether the variables were confounders or
variables with other relationships, such as collider or intervening variables. These other variables can also intro-
duce bias into the association between a diﬀerent independent variable and the outcome and be detected by algo-
rithm-based approaches.42,43,45,46
Taking confounders into account is crucial in observational studies, but readers should not assume that analyses
adjusted for confounders establish the “causal part” of an association. Results might still be distorted by residual
confounding (the confounding that remains after unsuccessful attempts to control for it),156 random sampling
error, selection bias, and information bias (see Box 1: Bias in observational studies).
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missing data were taken into account and became a
multidimensional additional parameter [].76
Explanation
Missing data are common in observational research.
Questionnaires are not always ﬁlled in completely, own-
ers might not bring their animal to all follow-up visits,
and routine data sources and clinical databases are often
incomplete. For analyses that account for missing data,
authors should describe the nature of the analysis (eg,
multiple imputation) and the assumptions that were
made (See Box 7: Missing data: problems and possible
solutions).
In cases where euthanized or culled animals are desig-
nated as missing data or observations lost to follow-up in
the analysis, the authors should clearly identify this crite-
rion as a cause of missing data. Describing this aspect of
the analysis is important, because the circumstances sur-
rounding culling or euthanasia are likely not to be ran-
dom, which violates the assumption that the missing data
are random. The approach for reporting missing observa-
tions or loss to follow-up is discussed in item 13.
12(d) If Applicable, Describe the Analytical
Approach to Loss to Follow-Up, Matching,
Complex Sampling, and Multiplicity of Analyses
Example
Conditional logistic regression [] was used to assess
diﬀerences in mean production (3.5% FCM, fat, pro-
tein, LSCC), JD test status as adults, removal from
herd during the observation period, and JD test sta-
tus of dam between cases and controls.77
Explanation
For cohort studies, authors should report whether they
conducted analyses to determine whether loss to follow-
up was diﬀerentially associated with other factors.
Another consideration is the approach for handling fail-
ure to observe the outcome, which can vary greatly
depending upon the disease frequency measure such as
rates or risk (Box 6: Measures of Association and mea-
sures of impact). In cohort studies that use rates such as
animal time at risk, the observed time of animals lost to
follow-up are included in the analysis, and the outcome is
censored. Because the approach used to analyze censored
data also varies, it should be described accordingly (see
item 7). When performing a survival analysis, an unob-
served outcome can be the result of loss to follow-up or
completion of the study. The authors should clearly state
whether the analysis treats these two forms of censoring
diﬀerently. When incidence risk (cumulative incidence) is
the disease frequency measure, authors should explain
how they interpreted data about animals that leave the
study before the end of the study.
In individually matched case-control studies, a crude
analysis of the odds ratio ignoring the matching, usually
leads to an estimation that is biased toward unity (see
Box 2: Matching in case-control studies).
When authors use complex, multiple-stage sampling
schemes to select the study population, authors should
describe how this scheme is incorporated into the data
analysis, thereby providing a valid estimate of eﬀect size
and precision.
When authors conduct multiple hypothesis tests, then
authors should indicate if they did or did not use a method
to adjust the deﬁnition of a “statistically signiﬁcant” P-
value. The description of the method should clarify
whether an adjustment approach for multiple comparisons
was employed within a speciﬁc hypothesis test.
12(e) Describe Any Analyses Used to Assess the
Robustness of the Analyses (eg, Sensitivity
Analyses or Quantitative Bias Assessment)
Example
The national database used to sample controls did
not enable us to take into account the size of the
ﬂocks. Therefore, counties with a large percentage of
small ﬂocks (<20 ewes) might have been overrepre-
sented. To assess the inﬂuence of geographic selec-
tion bias, we conducted a sensitivity analysis by
using 2 methods: (1) weighting of controls in the
ﬁnal model with weights being deﬁned for each
county as the ratio of the percentage of ﬂocks >20
ewes in the county divided by the percentage of
ﬂocks >20 ewes at the national scale, and (2) intro-
duction of sheep production areas as random coeﬃ-
cients in the ﬁnal model.78
Explanation
Sensitivity analyses are useful to investigate whether
or not the main results are consistent with those
obtained with alternative analysis strategies or assump-
tions.27 Issues that might be examined include the crite-
ria for inclusion in analyses, the deﬁnitions of exposures
or outcomes,79 which confounding variables merit
adjustment, the handling of missing data,80,81 possible
selection bias or bias from inaccurate or inconsistent
measurement of exposure, disease and other variables,
and speciﬁc analysis choices, such as the treatment of
quantitative variables (see item 11). Sophisticated meth-
ods are used increasingly to simultaneously model the
inﬂuence of several biases or assumptions82–84
Results
The results section should give a factual account of
what was found, from the recruitment of owners/man-
agers and their animals and the description of the study
populations to the main results and ancillary analyses.
The results should be reported in suﬃcient detail for
secondary use of the data (eg, for meta-analysis or risk
assessment). The results section should be free of inter-
pretations and discursive or overly discussive text
reﬂecting the authors’ views and opinions.
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13 Participants:
13(a) Report the Numbers of Owners/Managers
and Animals at Each Stage of Study and at Each
Relevant Level of Organization—For Example,
Numbers Eligible, Included in the Study,
Completing Follow-Up, and Analyzed
Example 1
During the study period, a total of 2,457 cats
attended the Small Animal Teaching Hospital. Of
these, 237 records were identiﬁed after the database
search, and 174 cases met the eligibility criteria.85
Example 2
Table 1 Structure of the data from 3,027 lactation
records from dairy cows on Reunion Island (1993–
1996)86
Level Number
Average number
per unit at next
higher level Range
Region (highest level) 5 – –
Herd 50 10 3–16
Cow 1,570 31.4 8–105
Lactation 3,027 1.9 1–5
Explanation
Detailed information on the process of recruiting
study participants is important for several reasons.
Those included in a study often diﬀer in relevant ways
from the target population to which results are applied.
This might result in estimates of prevalence or incidence
that do not reﬂect the experience of the target popula-
tion and lead to selection bias (see Box 1: Bias in obser-
vational studies).
Investigators should give an account of the numbers
of owners/managers and animals considered at each
stage of recruiting study participants and at each level
of organization. The choice of a target population and
the detailed criteria for inclusion of participants’ data in
the analysis should be described. Depending on the type
of study, this might include the number of owners/man-
agers and animals found to be eligible, the number
included in the study, the number examined, the num-
ber followed up, and the number included in the analy-
sis. Information on diﬀerent organizational levels might
be required, if sampling of study participants is carried
out at two or more organizational levels (multistage
sampling). In case-control studies, we advise that
authors describe the ﬂow of participants separately for
case and control groups.87 Controls can sometimes be
selected from several sources, including, for example,
veterinary clinics and community dwellers.
13(b) Give Reasons for Nonparticipation at Each
Stage and at Each Relevant Level of
Organization
Example 1
We investigated a total of 233 known OJD infected
ﬂocks to identify eligible ﬂocks, of which the eligibil-
ity of 32 (13.7%) could not be determined because
the farmer refused to participate for various reasons
(lack of interest (6), old age or health problems (4),
inability to muster sheep (2), anger about past sur-
veys (1) and no reason given (19)).88
Box 6 Measures of Association and Measures of Impact
The terms used to describe metrics in epidemiology are, unfortunately, not consistent. Therefore, care is needed
when deciding which concept is being described and if it is appropriate for a particular situation. For example,135
the Centers for Disease Control Principles of Epidemiology in Public Health Practice157 uses the term “Measures
of Association” to describe measures such as odds ratio, rate ratio. Although the online textbook ActiveEpi
(http://activepi.herokuapp.com/
courses/active-epi-course) uses the term “Measure of Eﬀect” to describe these measures. Regardless of the broad
grouping name used, these measures are usually the ratio of two measures of disease frequency. The relative mea-
sures emphasize the strength of an association and are most useful in etiologic research.
In addition, another set of measures are those designed to answer the question “How much of the disease burden
in a population could be prevented by eliminating the exposure?” The category used to describe these measures
again diﬀers by author. Dohoo et al135 use the term “Measures of Eﬀect,” the CDC Manual for Epidemiology
uses the term “Measures of Public Health Impact,” and Kleinbaum158 uses the term “Measures of Potential
Impact.” These calculations cover several concepts (and no unifying terminology) exist, and incorrect approaches
to adjust for other factors are sometimes used.107,159 For example, Kleinbaum suggests that the terms risk diﬀer-
ence (RD), attributable risk, and excess risk are synonyms.158 Similarly, Kleinbaum suggests that etiologic fraction
(EF) in the population can also be called the population attributable risk, the population attributable risk percent,
the population attributable risk proportion, and the population attributable risk fraction. The EF is appropriate
for cohort studies that estimate risk such as cumulative incidence. If the study measures incidence rate, these terms
change accordingly. Another measure is the etiologic fraction among exposed (EFe), which is alternatively called
the attributable risk percent among exposed, the attribute risk fraction among the exposed, and the attributable
risk proportion among the exposed. This measure focuses on the potential impact of the exposure on the number
of exposed cases, rather than the total number of cases of the disease. Regardless of the number used, authors
should be aware of the strong assumptions made in this context of using etiological fractions.106
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Example 2
Reasons for exclusion were lack of a result for serum
cobalamin (35 cats), cobalamin measured using a dif-
ferent method (13 cats), or incomplete clinical
records (15 cats). A record of prior cobalamin sup-
plementation (within the three months before presen-
tation) was identiﬁed in 18 cases (16 with serum
cobalamin greater than the reference interval, 1 with
cobalamin within the reference interval and 1 with
cobalamin below the reference interval).85
Explanation
Although low participation does not necessarily com-
promise the validity of a study, transparent information
on participation and reasons for nonparticipation are
essential. Also, as there are no universally agreed deﬁni-
tions for participation, response, or follow-up rates,
readers need to understand how authors calculated such
proportions.89,90 Explaining the reasons why owners/
managers or animals no longer participated in a study
or why they were excluded from statistical analyses
helps readers judge whether the study population was
representative of the target population and whether bias
was possibly introduced. For example, in a survey of
horse owners investigating an equine health outcome,
nonparticipation due to reasons unrelated to a horses’
health status (such as the survey not being delivered
due to an incorrect address) might aﬀect the estimate
precision but is not likely to introduce bias. Conversely,
if owners/managers opt out of the survey because their
horse is ill or perceived to be in excellent health, the
results might underestimate or overestimate the popula-
tion’s prevalence of ill health. If failure to participate or
loss to follow-up during the study is related to both an
exposure of interest and the outcome, the relationship
between the exposure and the outcome might also be
biased.
13(c) Consider Use of a Flow Diagram, A
Diagram of the Organizational Structure, or
Both
Example
Figure extracted from publication91
Explanation
An informative and well-structured ﬂow diagram can
readily and transparently convey information that
might otherwise require a lengthy description.92 The
diagram might usefully include the main results such as
the number of events for the primary outcome. The
Box 7 Missing Data: Problems and Possible Solutions
Missing data are common in observational research. In studies conducted in populations with multiple organiza-
tional levels, missing data might occur and need to be described at multiple levels. Rubin developed a typology
of missing data problems, based on a model for the probability of an observation being missing.160,161 Data are
described as missing completely at random (MCAR) if the probability that a particular observation is missing
does not depend on the value of any observable variable(s). Data are missing at random (MAR) if, given the
observed data, the probability that observations are missing is independent of the actual values of the missing
data. For example, suppose younger dairy heifers are more prone to missing pregnancy checks, but the probabil-
ity of missing the check is unrelated to the true pregnancy risk after accounting for age. Then, the missing preg-
nancy measurements would be MAR in models including age. Data are missing not at random (MNAR) if the
probability of missing still depends on the missing value even after taking the available data into account. When
data are MNAR, valid inferences require explicit assumptions about the mechanisms that led to missing data. In
studies with multiple organizational levels, data might be missing at the individual level, group level, or both.
For example, the probability of loss to follow-up might depend on both group and individual characteristics.162
Methods to deal with data missing at random (MAR) fall into three broad classes:160,161 likelihood-based
approaches,163 weighted estimations,164 and multiple imputation.165–167 Options for dealing with missing data in
veterinary literature have recently been published, along with an assessment to determine the magnitude of bias
that might arise from a complete-case analysis.168
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ﬂowchart might need to include information for both
owners/managers and animals as well as information at
multiple organizational levels, if applicable.
14 Descriptive Data on Exposures and Potential
Confounders:
14(a) Give Characteristics of Study Participants
(eg, Demographic, Clinical, Social) and
Information on Exposures and Potential
Confounders by Group and Level of
Organization, If Applicable
Example
Example 2
Explanation
Readers need descriptions of study participants and
their exposures to judge the generalizability of the
ﬁndings or use the data in secondary analyses. In vet-
erinary studies, this might include descriptive informa-
tion about the owners/managers, herds, pens, and
animals. In studies that compare groups, the descrip-
tive characteristics and numbers should be given by
group. The “group” variable would be exposure level
or outcome status, depending on the study subject
selection method. Inferential measures such as stan-
dard errors and conﬁdence intervals should not be
used to describe the variability of characteristics, and
signiﬁcance tests and P-values should be avoided
when describing the baseline characteristics of the
study population. In cohort studies, it might be useful
to document how an exposure relates to other charac-
teristics and potential confounders. Authors could
present this information in a table with columns for
participants in 2 or more exposure categories, which
permits the reader to judge the diﬀerences in con-
founders between these categories.
Information about potential confounders, including
whether and how they were measured, inﬂuences judg-
ments about study validity. We advise authors to summa-
rize continuous variables for each study group by giving
the mean and standard deviation, or, when the data have
an asymmetrical distribution (as is often the case), the
median and percentile range (eg, 25th and 75th per-
centiles). Variables made up by small number of ordered
categories (such as stages of disease I to IV) should not
be presented as continuous variables; it is preferable to
give numbers and proportions for each category. The
SAMPL guidelines provide recommendations for report-
ing descriptive statistics for diﬀerent variable types.74 We
recommended that descriptive information be provided
for all variables measured in the study, regardless of
whether they are included in the ﬁnal analyses. To allow
the reader to evaluate the statistical power for an individ-
ual variable and the probability of a type I error given the
total number of variables evaluated, authors should pro-
vide information on the number of variables and the dis-
tribution of data among each variable’s categories. Some
journals might be reluctant to publish extensive descrip-
tive tables due to word limits or page constraints. In these
cases, we recommend that the descriptive information be
provided as supplementary material and the total number
of associations tested be provided in the main text. The
approach for presenting inferential statistics is dis-
cussed in item 15. The decision to combine descriptive
statistics (item 13) and inferential statistics (item 15), into
one table, as was done in the example provided for this
item, depends on author and journal preference.
Table 2 Descriptive statistics for variables of interest in calves born in fall 2005–200837
Year Pinkeye: n ADG: kg/d (SD) URFAT: cm (SD) UFAT: cm (SD) UREA: cm2 (SD) UPFAT: % (SD) LIVE WT: kg (SD)
2005 Case: 15 0.92 (0.37) 0.58 (0.38) 0.53 (0.36) 55.13 (17.55) 4.45 (1.02) 344.40 (98.91)
Neg: 92 1.01 (0.40) 0.66 (0.34) 0.62 (0.38) 60.21 (16.48) 4.72 (1.12) 382.59 (100.75)
2007 Case: 9 0.98 (0.55) 0.60 (0.42) 0.54 (0.43) 59.90 (22.45) 4.27 (0.99) 380.16 (140.17)
Neg: 123 0.98 (0.49) 0.65 (0.39) 0.59 (0.35) 60.69 (18.23) 4.55 (0.98) 381.99 (116.58)
2008 Case: 3 0.76 (0.39) 0.70 (0.45) 0.62 (0.34) 53.10 (18.26) 4.55 (0.32) 353.95 (120.51)
Neg: 126 1.02 (0.37) 0.71 (0.29) 0.65 (0.31) 65.77 (17.80) 4.76 (1.15) 406.73 (96.51)
Total Case: 27 0.92 (0.42) 0.59 (0.39) 0.55 (0.37) 56.50 (18.79) 4.41 (0.94) 357.38 (112.73)
Neg: 341 1.00 (0.42) 0.67 (0.34) 0.62 (0.34) 62.44 (17.75) 4.63 (1.09) 391.29 (105.63)
Table 1 Descriptive statistics (mean, [SD, median, min, max]) for PA-MNT (pressure algometry-mechanical nociceptive
threshold in kg/f) for calves scarified on d 0 (n = number of eyes)93
d (n) Landmark 1 Landmark 2 Landmark 3 Landmark 4 (Control)
Scariﬁed eyes
4 (19) 5.2 (1.9, 4.8, 1.4, 10.1) 2.0 (1.2,1.8,0.2,6.5) 4.0 (2.4, 3.7, 0.5, 10.3) 5.5 (2.2, 5.2, 1.1, 11.1)
1 (19) 3.9 (1.9, 3.7, 0.7, 10.0) 1.7 (1.1, 1.4, 0.1, 5.1) 3.1 (2.1, 2.5, 0.1, 8.3) 3.9 (1.7, 3.9, 0.7, 11.2)
3 (16) 3.1 (1.2, 3.0, 0.9, 6.9) 1.3 (0.8, 1.2, 0.2, 3.3) 2.6 (2.5, 1.6, 0.2, 11.2) 3.2 (1.1, 3.2, 0.4, 6.6)
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14(b) Indicate Number of Participants with
Missing Data for Each Variable of Interest and
at all Relevant Levels of Organization
Example
In total 112 farmers returned useable prospective
records on 2,143 litters. . . . Cause and timing of
piglet death data were returned for 2,826
piglets from 1,304 litters from 111 farms. . . . With
the exception of unknown sow parity, incom-
plete piglet mortality records were excluded from
the risk factor analysis, this amounted to 1,714 pig-
let records. Data on a cohort of 25,761
piglets from 2,143 litters from 112 farms were
analysed.94
Explanation
As missing data might bias or aﬀect generalizability
of results, authors should tell readers the amounts of
missing data for exposures, potential confounders, and
other important characteristics of study subjects (see
item 12c and Box 7: Missing data: problems and possi-
ble solutions). Authors should clearly describe the num-
ber of animals missing due to elective euthanasia or
culling. Authors also should report numbers at each
level or organization. A study with a small number of
missing observations from each herd might have diﬀer-
ent implications than a study where all of the missing
data are from one herd. We advise authors to use their
tables and ﬁgures to enumerate amounts of missing
data.
14(c) Summarize Follow-Up Time (eg, Average
and Total Amount), If Appropriate to the Study
Design
Example
A total of 548 calves were recruited and followed
up to 51 weeks or until they died, contributing a
total of 25,104 calf weeks (481.1 calf years) of life
to the study. Five animals were lost to follow up
due to non-compliance to study protocol or were
stolen from the study farms. A total of 88 calves
died before reaching 51 weeks of age, giving a
crude mortality rate of 16.1 (13.0–19.2; 95% CI)
per 100 calves in their ﬁrst year of life. Of the 88
animals that died, 33 deaths were attributed to
East Coast fever, 10 to haemonchosis, and 6 to
heartwater.95
Explanation
Readers need to know the duration and extent of
follow-up for the available outcome data. Authors can
present a summary measure of the follow-up such as
the mean follow-up time, median follow-up time, or
both, as appropriate. The mean allows a reader to
estimate the total number of animal-years by multiply-
ing it with the number of study subjects. Authors also
might present minimum and maximum times or per-
centiles of the distribution to show readers the
spread of follow-up times. They might report total
animal-years of follow-up or some indication of the
proportion of potential data that were captured96 All
such information might be presented separately for
animals in 2 or more exposure categories.
15 Outcomes
Example 1
In the reduced dataset of 200 cats, 126 (63%) cats
were classed as overweight and 74 (37%) as normal
weight. The BCS distribution for the study popula-
tion without the cats that were excluded on medical
grounds (n = 206) as shown in . . ..
Table 3 Variables assessed as potential risk factors
for being obese or overweight (O/wgt) grouped accord-
ing to model of 200 cats included in the study (New
Zealand 2007)97
Model Variable
Category
levels Cats (n)
O/wgt
(%)
P-
value
Cat
characteristics
Age
(years)a
≤2 29 41 .002
3–7 87 60
8–12 58 69
≥13 24 88
Desexed?a Entire 9 11 .002
Desexed 190 65
Sex Male 109 66 .463
Female 92 60
Example 2
Table 4 Multivariable model of risk factors for the
occurrence of Campylobacter at ﬁrst depopulation in
354 conventional broiler ﬂocks in Northern Ireland,
June 2001 to May 200298
Variable
No.
of
ﬂocks
Positive
(%)
Odds
ratio 95% CI
P-value
(Wald’s)
P-
value
of
factor
Age at
samplinga
Per day
increase
354 42.9 1.16 1.05–1.28 .005 .004
Number of houses on site
One 125 31.2 1 – – .018
Two 88 39.8 1.39 0.60–3.21 .447 –
Three
or more
141 55.3 2.86 1.32–6.22 .008 –
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Example 3
The FEC results were reported as ep5 g [eggs per 5
grams of feces]. The range of egg counts was from
0 to 419 ep5 g. Table III summarizes the range,
mean, and median counts for the 4 regions.
Table III Summary statistics for 1947 fecal egg
counts of Trichostrongyle-type eggs per 5 g of feces
(ep5g) from samples collected from 38 Canadian dairy
herds.99
Range Mean Median SD Variance N
PEI 0–419 12.8 2 37.8 1,428.5 1,016
Quebec 0–241 7.8 1 23.6 558.7 610
Ontario 0–48 2.2 0 6.1 37.2 163
Saskatchewan 0–189 5.6 0 25.5 652.7 157
Overall 0–419 9.8 1 29.0 998.7 1,946
SD, standard deviation.
Explanation
Before addressing the possible association between
exposures (risk factors) and outcomes, authors should
report relevant descriptive data. It might be possible
and meaningful to present unconditional measures of
association in the same table that presents the descrip-
tive data.
15(a) Report Outcomes as Appropriate
for the Study Design and Summarize
at all Relevant Levels of
Organization
Item 15 diﬀers from item 14, in that 15 explicitly
relates to the outcome (event) information. In cross-
sectional and risk-based cohort studies, authors should
report the number of events for each outcome of inter-
est. For example, in Example 1, this information is pro-
vided in the table. Consider presenting this information
separately for participants in diﬀerent categories of key
exposures of interest. Example 1 also includes informa-
tion relevant to item 14 such as information about the
distribution of potential confounders. For rate-based
cohort (longitudinal) studies, consider reporting the
event rate per animal-year of follow-up. For case-
control studies, the focus will be on reporting exposures
separately for cases and controls as frequencies or
quantitative summaries.
Describing the outcome at all organizational levels
requires balancing between complete reporting and “in-
formation overload.” If the outcome analyses are all
carried out at the lowest level, the outcome at all higher
levels might not be need to be reported. However, the
authors should provide the reader with some idea as to
how the outcome varies across higher level units. In
Example 3, the hierarchy consisted of province (n = 4),
herd (n = 38), cow (n = 304), and sample (n = 1,946).
The authors provided some evidence of the variability
in fecal egg count across provinces by providing
descriptive statistics in a tabular form by province. In
some cases, it might be appropriate to report the out-
come at diﬀerent time points (eg, for a longitudinal
study).
In Example 4, the organizational levels were herd
(n = 210) and cows (n  5,000). To indicate the range
of incidence rates of several diseases across herds, they
presented those rates as box-and-whisker plots, which
eﬀectively convey the cross-herd variability. When ﬁg-
ures are used for presentational clarity, tables of numer-
ical values, which are required for meta-analyses and
risk analyses, should be included in the main text or
supplemental material.
Multilevel studies are often analyzed using random
eﬀects models. In these cases, the authors should pre-
sent the variance estimates at all levels to provide infor-
mation about the outcome variability across all
organizational levels.
15(b) For Proportions and Rates, Report the
Numerator and Denominator
It is important to present both numerator and
denominator values, so users can calculate uncondi-
tional risk ratios (RR) or odds ratios (OR). In Example
1 (cross-sectional study), the number of animals in the
exposure variable categories and the percent with the
outcome are reported. These values allow the reader to
compute the numerator and denominator values for a
RR. In Example 2 (case-control study), the actual
numerator and denominator values (listed by key
exposure variable categories) and the associated ORs
are presented. For rate-based studies, the number
of outcome events and amount of animal time at risk
should be presented for key predictor categories.
15(c) For Continuous Outcomes,
Report the Number of Observations
and a Measure of Variability
For quantitative outcomes, present appropriate sum-
mary measures. For (approximately) normally dis-
tributed values, the authors should report the mean and
standard deviation (SD) or variance. We do not recom-
mend reporting the standard error of the mean, because
standard error is an inferential statistic rather than a
descriptive one. For non-normally distributed outcomes,
either report the mean and SD of a normally dis-
tributed transformed outcome or consider reporting the
median and interquartile range (or complete range)
of the original variable. In Example 3, the mean and
SD as well as the median and range have been
presented.
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16 Main Results
16(a) Give Unadjusted Estimates and, If
Applicable, Adjusted Estimates and Their
Precision (eg, 95% Conﬁdence Interval). Make
Clear Which Confounders and Interactions were
Adjusted. Report all Relevant Parameters that
were Part of the Model
Example 1
Table 2 Example 1: Model estimates of the eﬀects of
alternative confounder adjustments based on data from
Table 1
# of cattle purchased
from positive herds
in the previous quarter
Full model
ORf
estimatesa
Simpliﬁed model
ORf estimates
Crude
ORf
1b 2c 3d
>20 7.4 8.1 9.7 9.9 9.7
10–20 11.0 11.9 14.2 13.8 14.2
1–10 3.8 3.8 5.0 4.8 5.0
For details on the multivariable model, see100
aBased on the full model with four signiﬁcant risk factors as
presented by Nielsen et al (2007).
bModel 1: as the full model without the risk factor: “herd size.”
cModel 2: as Model 1 without the risk factor: “region of the
country.”
dModel 3: as Model 2 without the risk factor: “number of Sal-
monella-positive herds in the previous quarter within a 2 km
radius,” that is, model with the primary risk factor, controlling
for repeated measurements within herds).101
Example 2
Table 3 Final multivariable random effects logistic regression models of associations between barn thermal environment
parameters, pig-, pen-, and cohort-level risk factors and Salmonella shedding in finishing pigs in three sites. Multilevel
multivariable logistic models with random intercepts at pig, pen, and cohort levels
Models
Measured
at level
Independent
variable Betaa SEb ORc 95% CId P-valuee
Model 1
Intercept 2.65 0.58 – – –
Pig Agef 1.18 0.017 0.7 0.65–0.74 <0.001
Pen Cold
exposure
12hi
0.44 0.2 1.51 1.02–2.25 0.03
Cohort Nursery
statusg
2.16 0.52 4.14 2.79–17.15 <0.001
Farm Site
A versus B 0.93 0.61 2.52 0.76–8.42
A versus C 0.38 0.63 1.46 0.42–5.04
B versus C 1.3 0.64 3.69 1.06–12.86
Cohort (Varh = 0.77 (0.43), % = 11.48); Pen (Varh = 1.69 (0.34), % = 25.19); Pig (Varh = 0.96 (0.21), % = 14.31); Total (Varh = 6.71)
Cohorts (n = 18); Pens (n = 361); Pigs (n = 899); Individual fecal samples (n = 6,751); Salmonella prevalence (6.58%).
h Variance components, standard error, and proportion of variance at the cohort, pen and pig levels. Individual fecal sample variance:
p 2/3=3.29 (latent variable technique).102
Explanation
In many situations, authors might present the results
of unadjusted or minimally adjusted analyses and those
from fully adjusted analyses. We advise giving the
unadjusted analyses together with the main data, for
example, the number of cases and controls that were
exposed or not. This allows the reader to understand
the data behind the measures of association (see also
item 15). For adjusted analyses, report the number of
animals in the analysis, as this number might diﬀer
because of missing values in covariates (see also item
12c). Estimates should be given with conﬁdence
intervals.
Readers can compare unadjusted measures of associa-
tion with those adjusted for potential confounders and
judge by how much, and in what direction, they chan-
ged. Readers might think that “adjusted” results equal
the causal part of the measure of association, but
adjusted results are not necessarily free of random sam-
pling error, selection bias, information bias, or residual
confounding. Thus, great care should be exercised when
interpreting adjusted results, as the validity of results
often depends crucially on complete knowledge of
important confounders, their precise measurement, and
appropriate speciﬁcation in the statistical model (see
also item 20).103,104
Data nonindependence is frequently encountered in
animal studies and often addressed by ﬁtting a random
eﬀects model. It is important that these random eﬀects
be reported (and interpreted), because they are as
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important a model component as the ﬁxed eﬀects (see
Example 2).
16(b) Present Category Boundaries When
Continuous Variables were Categorized
Explanation
Categorizing continuous data has several important
implications for analysis (Box 3: Grouping/Categoriza-
tion) and also aﬀects the presentation of results. In
tables, outcomes should be given for each exposure
category, for example, as counts of animals at risk,
animal time at risk, if relevant separately for each
group (eg, cases and controls). Details of the categories
used might aid comparison of studies and meta-analy-
sis. If data were grouped using conventional cut points
(eg, below normal, normal reference range, above nor-
mal for body temperature), group boundaries such as
range of values can be derived easily, except for the
highest and lowest categories. If quantile-derived cate-
gories are used, the category boundaries cannot be
inferred from the data. At a minimum, authors should
report the category boundaries; it is helpful also to
report the range of the data and the mean or median
values within categories. Commonly, category bound-
aries are presented directly in the table with model
results (see Example 1).
16(c) If Relevant, Consider Translating
Estimates of Relative Risk into
Absolute Risk for a Meaningful
Time Period
Example
Table 4 Population attributable fraction (PAF) and
95% conﬁdence interval for selected explanatory vari-
ables regarding 295 dog owners in Taiwan (2004)
PAF (%)
95% CI
Lower
limit
Upper
limit
History of unsuccessful
ownership
33 11 50
Spayed after giving birtha 22 3 37
Soiling 17 6 26
Barking 13 1 23
Barking and soiling combined 23 3 40
Neighbor complaintsb 11 1 20
a Do you think that a female dog would be healthier if she had
one litter before being ﬁxed?
b Have there been any neighborhood problems or complaints
concerning your dog?105
Explanation
In many circumstances, the absolute risk associated
with an exposure is of greater interest than the relative
risk. Absolute measures such as risk diﬀerent and mea-
sures of impact such as etiological fraction in the
exposed or etiological fraction in the population might
be useful to gauge how much disease can be prevented
if the exposure is eliminated (example above). For this
reason, such measures are of interest to the end users.
These measures should preferably be presented
together with a measure of statistical uncertainty,
although CI calculations might be diﬃcult for esti-
mates derived from multivariable models. Authors
should be aware of the strong assumptions made in
this context, including a causal relationship between a
risk factor and disease (also see Box 6: Measures of
Association and measures of impact). 106 Because of
the semantic ambiguity and complexities involved,
authors should report the method used to calculate
such measures, ideally giving the formulae used or a
citation for the formula. 107
17 Other Analyses: Report Other Analyses Done,
Such as Sensitivity/Robustness Analysis and
Analysis of Subgroups
Examples
Sensitivity testing was done for each model by lower-
ing prior test accuracy estimates’ mode by 10 per-
centage points (eg., ELISASe from 0.95 to 0.85),
relaxing the beta distribution to a 50th percentile
and reducing the lower bound 10 percentage points
below the previous lower bound (eg., ELISASe from
0.9 to 0.8) and using a uniform beta distribution as
the prior distribution for exposure prevalence.108
Explanation
When an observational study has a single primary
question, the reader reasonably might assume that all
the study design features were selected with that ques-
tion in mind (eg, sample size and power, the interpreta-
tion of the alpha error, accuracy enhancement and bias
reduction measures, and potential confounders). If addi-
tional questions and analyses were included in the
study, the authors must tell the readers. Lack of full
disclosure distorts the interpretation of everything from
bias control eﬀectiveness to multiplicity considerations.
The reader must be informed of all secondary analyses
(eg, conducting sensitivity analyses, or testing for inter-
actions or particular subgroup analyses) that were pre-
speciﬁed (eg, a priori) or were steered by the data
themselves (post hoc analyses). For example, “non-
signiﬁcant” interactions or risk factors are “results”
unto themselves, and they assist in framing the context
of “signiﬁcant” results. Post hoc subgroup analyses that
appear more “exciting” than the answers to the primary
question must be viewed cautiously.
Researchers often must extrapolate the “base” values of
relevant input data. Examples include declaring prior dis-
tributions for Bayesian analyses and declaring the diagnos-
tic test accuracy used for adjusting apparent prevalences
to true prevalences. In some instances, distributions are
unknown or variables have great inherent contextual vari-
ation, which leads to considerable uncertainty. When
faced with such assumptions about uncertainty, authors
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should conduct “sensitivity analyses” to discover the sensi-
tivity (robustness) of the conclusions with respect to rea-
sonable variation from base values. Additionally, the data
often lead to decisions about diagnoses or other catego-
rizations; however, alternative decision criteria might be
available. In these situations, it is also appropriate to
examine and report the sensitivity of the conclusions with
respect to the decision criteria used.
Discussion
The discussion section provides readers with the
authors’ interpretation of the results once they have been
placed in context such as the approach to the study and
prior relevant ﬁndings. Authors should also emphasize
the study design aspects that enhance the internal and
external validity of the ﬁndings to aid the readers’ under-
standing of the data and the conclusion’s strength. In
addition, the authors should outline the limitations of the
design and their impact on the ﬁndings.
18 Summarize Key Results with Reference to
Study Objectives
Examples
. . .a large ﬁeld data collection from 14 endemically
infected dairy herds was used to investigate the
hypothesis that cattle with persistently high antibody
levels are at high risk of shedding S. Dublin and there-
fore are candidates to be culled or at least managed so
that they do not spread the infection to herd mates.
Despite that fact that there were seropositive animals
in many of the age groups at most of the herd visits,
indicative of the herds being endemically infected, the
general probability of shedding was very low . . . for S.
Dublin. . . . Based on this study material there was no
evidence that animals with persistently high antibodies
over a period of at least 6 months were at higher risk
of shedding S. Dublin bacteria in their faeces than
other seropositive cattle.109
Explanation
It is good practice to begin the discussion with a
short summary of the main ﬁndings of the study. The
short summary reminds readers of the main ﬁndings
and might help them assess whether the subsequent
interpretation and implications oﬀered by the authors
are supported by the ﬁndings.
19 Discuss Strengths and Limitations of the
Study, Taking into Account Sources of Potential
Bias or Imprecision. Discuss Both Direction and
Magnitude of Any Potential Bias
Example
Because of the steps involved in making a diagnosis
of leptospirosis . . . it is unlikely that a dog exam-
ined at a veterinary teaching hospital would be
falsely diagnosed as having leptospirosis when it did
not. It is more likely that leptospirosis was not
diagnosed in some dogs with the disease. This of
bias is unlikely to be substantial, because the num-
ber of dogs with undiagnosed leptospirosis is proba-
bly a very small proportion of all dogs examined at
veterinary teaching hospitals. For example, if lep-
tospirosis had been underdiagnosed by a factor of
10-fold, <0.04% of the 1,819,792 dogs examined at
veterinary teaching hospitals between 1970 and 1998
would have been classiﬁed as cases rather than con-
trols. For the age category 4–6.9 years, this bias
would result in a change in the estimated OR from
1.7259 to 1.7295 (a change of 0.21%), assuming
equal proportions of misdiagnoses in the 4–6.9 years
and <1 year age categories. We do not expect the
proportion of dogs with leptospirosis in which the
disease is not diagnosed at veterinary teaching hos-
pitals to be greater than 10-fold that recorded in
the VMDB, so bias from misclassiﬁcation of lep-
tospirosis status was unlikely to be substantial in
this study.110
Explanation
Authors should highlight speciﬁc strengths of their
study relative to other work in the ﬁeld (eg, a study based
on true random sampling versus convenience sampling).
However, the identiﬁcation and discussion of the limi-
tations of a study are an essential part of scientiﬁc
reporting. It is important not only to identify the
sources of bias and confounding that could have
aﬀected results, but also to discuss the relative impor-
tance of diﬀerent biases, including the likely direction
and magnitude of any potential bias (see Box 1: Bias
in observational studies and Box 5: Confounding and
item 9 about bias in method and materials).
Authors should also discuss the impact of imprecision
and uncertainty on the interpretation of results. Result
imprecision could result from a small sample size, which
produces a wide CI such as low eﬀect size precision.
Here, we refer to uncertainty as missing knowledge
related to speciﬁc factors, parameters, or model speciﬁ-
cation rather than sample size.111
When discussing limitations, authors might compare
the study being presented with other studies in the liter-
ature in terms of validity, generalizability, and preci-
sion. In this approach, each study can be viewed as a
contribution to the literature, not as a stand-alone basis
for inference and action.112
20 Give a Cautious Overall Interpretation of
Results Considering Objectives, Limitations,
Multiplicity of Analyses, Results from Similar
Studies, and Other Relevant Evidence
Examples
We conclude that the presence of unresolved infection
in a herd is a contributor to further bTB episodes in
the ﬁrst 2 years after clearance. These ﬁndings agree
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with the investigations in the UK and Ireland, which
have shown repeatedly that bTB spreads from de-
restricted herds to clear herds via the transfer of unde-
tected infection after de-restriction [].113
Explanation
In accordance with the original STROBE document,
we encourage authors to provide the reader with a
thoughtful conclusion and a rationale based on the
principles of causal inference rather than using P-values
<.05 (or any other arbitrary P-value cutoﬀ) as an indi-
cator of a causal association. The heart of the discus-
sion section is the interpretation of a study’s results.
When interpreting results, authors should consider the
place of the study on the discovery-to-veriﬁcation con-
tinuum and potential sources of bias, including loss to
follow-up and nonparticipation (see also items 9, 12
and 19).
In the veterinary ﬁeld, studies evaluating large num-
bers of independent variables are common occurrences.
The probability that at least one signiﬁcant ﬁnding will
be a type I error increases as the number of hypotheses
tested within a study increases. Therefore, in the limita-
tions section, authors should note the probability of
type I errors as an alternative explanation for the asso-
ciations observed when appropriate.
The rationale should address the concepts used to
establish causation. The conclusions presented should
consider the role chance and bias could play in the ﬁnd-
ings of the current study (discussed in item 19) as well as
those of previous studies on the same topic. Currently,
many guides on causal thinking exist, such as those pro-
posed by Bradford Hill and others. 114–116 Although we
are not proposing a formulaic application of guidelines
or criteria, readers might ﬁnd it helpful if the authors
document the concepts of causal inference to assist them
in understanding the conclusion. For example, how
strong is the association with the exposure? Did exposure
precede disease onset? Is the association consistently
observed in diﬀerent studies and settings? Is there sup-
porting evidence from experimental studies, including
laboratory and animal studies? How speciﬁc is the expo-
sure’s putative eﬀect, and is there a dose-response
relationship? Is the association biologically plausible? A
discussion of the existing external evidence, from diﬀer-
ent types of studies, should always be included, but might
be particularly important for studies reporting small
increases in risk. Furthermore, authors should put their
results in context with similar studies and explain how
the new study aﬀects the existing body of evidence, ide-
ally by referring to a systematic review.
21 Discuss the Generalizability (External
Validity) of the Study Results
Example
The ﬁndings from this study would be diﬃcult to
extrapolate to other countries, because of the diﬀer-
ences in bTB management policies between countries.
However, this study has added weight to the growing
body of evidence to show that residual infection in
herds poses a problem to bTB eradication schemes,
and that the goal should be to maximize within-herd
sensitivity in the management of this problematic
infection.113
Explanation
Generalizability, also called external validity or appli-
cability, is the extent to which the results of a study can
be applied to other circumstances. 117 There is no exter-
nal validity per se; the term is meaningful only with
regard to clearly speciﬁed conditions. 118 Can results be
applied to an individual, groups, or populations that dif-
fer from those enrolled in the study with regard to age,
sex, breed, or other characteristic, such as the production
system for livestock populations? Are the nature and
level of exposures comparable, and the deﬁnitions of out-
comes relevant to another setting or population? Are
results from one country applicable to other countries?
The question of whether the results of a study have
external validity is often a matter of judgment that
depends on the study setting, the characteristics of the
participants, the exposures examined, and the outcomes
assessed. Thus, it is crucial that authors provide readers
with adequate information about the setting and
Box 8 Interaction (Eﬀect Modiﬁcation): The Analysis of Joint Eﬀects
Interaction exists when the association of an exposure with the risk of disease diﬀers in the presence of another
exposure. One problem in evaluating and reporting interactions is that the eﬀect of an exposure can be measured in
two ways: as a risk ratio (or rate ratio) or as a risk diﬀerence (or rate diﬀerence). The use of the ratio leads to a
multiplicative model, whereas the use of the diﬀerence corresponds to an additive model.169,170 A distinction is
sometimes made between “statistical interaction” which can be a departure from either a multiplicative or additive
model, and “biologic interaction” which is measured by departure from an additive model.171 However, neither
additive nor multiplicative models point to a particular biologic mechanism. Regardless of the model choice, the
main objective is to understand how the joint eﬀect of two exposures diﬀers from their separate eﬀects (in the
absence of the other exposure). The Human Genomic Epidemiology Network (HuGENet) proposed a layout for
transparent presentation of separate and joint eﬀects that permits evaluation of diﬀerent types of interaction.172 A
diﬃculty is that some study designs, such as case-control studies, and several statistical models, such as logistic or
Cox regression models, estimate risk or rate ratios and intrinsically lead to multiplicative modeling.
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locations, eligibility criteria, the exposures and how they
were measured, the deﬁnition of outcomes, and the per-
iod of recruitment and follow-up. The degree of nonpar-
ticipation and the proportion of unexposed participants
in whom the outcome develops are also relevant. Knowl-
edge of the absolute risk and prevalence of the exposure,
which will often vary across populations, are helpful
when applying results to other settings and populations.
Of course, the need for inclusion of these features is dis-
cussed throughout this document and these summary
statements only serve as a reminder of the need for com-
plete reporting of research design and results in the con-
text of external validity (See Box 6: Measures of
Association and measures of impact).
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22 Transparency
22(a) Give the Source of Funding and the Role of
the Funders for the Present Study and, If
Applicable, for the Original Study on Which the
Present Article is Based
Example
Funding: This study was funded by Pﬁzer Animal
Health (www.Zoetis.com). The grant number was 1329.
The following Pﬁzer personnel were observers during
the study: Jeremy Salt, Michael Pearce, Tony Simon
and Marie-Odile Hendrickx. The funders had no role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript, except
attendance at project coordination meetings as obser-
vers, and commenting on the draft manuscript.119
Explanation
Because of concerns about funding agencies’ inﬂuence
on study design and the potential for selective reporting,
funding sources and the role of funding agencies should
be described explicitly. In human health, several investi-
gations show strong associations between the source of
funding and the conclusions of research articles.120–123
To our knowledge, there are no similar associations
detected in observational studies conducted in veterinary
science. However, the possibility for bias could exist, and
it is best practice to disclose all funding sources.
22(b) Conﬂicts of Interest. Describe any Conﬂicts
Of Interest, or Lack Thereof, for Each Author
Dr. . . . has provided scientiﬁc consulting services to
Zoetis Inc. (manufacturer of the CCFA product).
This does not alter the authors’ adherence to all the
journal policies on sharing data and materials.124
Explanation
In human health, there is evidence that authors or
funders might have conﬂicts of interest that inﬂuence
any of the following: the design of the study,125
choice of exposures,125,126 outcomes,127 statistical
methods,128 and selective publication of outcomes and
studies.127,129 Potential conﬂicts of interest include
ﬁnancial arrangements outside of research funding
that could inﬂuence authors. Authors should disclose any
ﬁnancial support, including grants, scholarships, and
sponsorships received. Gifts that might not be associated
directly with the project, such as laboratory equipment,
travel, consulting agreements, and honoraria, but still
establish a relationship with a company or agency should
also be disclosed. This information alerts users the rela-
tionship and allows them to assess the potential for bias
in conducting and reporting the study.
22(c) Describe the Authors’ Roles—Provision of
an Author’s Declaration of Transparency is
Recommended
Example
H.M.S., B.N., G.H.L. and P.B. conceived and
designed the study. N.K., H.M.S., B.N., G.H.L., J.V.,
P.B., J.L.C. and G.C. performed the experiments.
N.K., H.M.S., B.N., G.H.L., P.B., M.M.C. and J.B.
analyzed and interpreted data. N.K. and H.M.S.
drafted the manuscript. All authors revised manu-
script for critically important intellectual content and
approved the ﬁnal version to be published.124
Explanation
A declaration of transparency should contain two
parts: the authors’ roles in the study and a declaration
of complete reporting. Declarations of transparency do
not address any potential bias within the study. They
are primarily designed to ensure that all authors meet the
criteria for authorship (http://www.icmje.org/
recommendations/browse/roles-and-responsibilities/deﬁning-
the-role-of-authors-and-contributors.html). Those per-
sons not meeting the authorship criteria can be referenced
in the acknowledgements section, but it is unethical to
include them as authors. The declaration of complete
reporting was proposed by Altman130 and is a statement
acknowledging that the data have been reported in their
entirety and none of the study has been omitted, thus
reducing the potential for selective reporting.
22(d) Ethical Approval—Include Information on
Ethical Approval for Use of Animal and Human
Subjects
Example
The study was performed in adherence to the
University of Liverpool Animal Ethics Guidelines.85
Explanation
When studies involve animal use, authors must
obtain ethical approval. It is consistent with best
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practices and transparency to report the agency in
charge of approval and a veriﬁcation number to identify
the approval. In some studies, particularly those using
questionnaires, authors must document that they
received approval for recruiting human participants in
research.
22(e) Quality Standards—Describe any Quality
Standards Used in the Conduct of the Research
Example
. . .reported according to the guidelines of the
Strengthening the Reporting of Observational Stud-
ies in Epidemiology (STROBE) statement, see addi-
tional information (STROBE Checklist) for further
details.131
Explanation
When standards, such as STROBE, are available and
have been used, authors should explicitly state their use,
so end users are aware of their implementation and can
validate that they were followed. Further, some stan-
dards are lengthy, and it might be impractical to include
a full description of the methods employed in the paper.
For example, laboratory or animal welfare accredita-
tions indicate that certain practices and quality control
approaches were followed, and this information can
help end users assess bias.
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